DECOR Information for Project: epSOS (epsos-)

Issues already assigned

Currently assigned to: Giorgio Cangioli (id 5)

 (epsos-issue-2) Add laparoscopic colectomy
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.2)
Last assignment to Giorgio Cangioli

Issue Add laparoscopic colectomy
Id epsos-issue-2
Type Change Request
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-10 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSProcedures 1.3.6.1.4.1.12559.11.10.1.3.1.42.10 July 2009 - 2013‑06‑03 Draft
notice There are open issues with this item:
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 19063003 Arthroplasty of knee SNOMED-CT Hospital Data Project WHO
0-L 84877006 Arthroscopy of knee with meniscus repair SNOMED-CT TOP 20 Germany
0-L 119922005 Biliary tract endoscopy SNOMED-CT TOP 20 Germany
0-L 86273004 Biopsy SNOMED-CT
0-L 10847001 Bronchoscopy SNOMED-CT Hospital Data Project WHO
0-L 112802009 Cardiovascular surgical procedure SNOMED-CT
0-L 250980009 Cardioversion SNOMED-CT
0-L 66951008 Carotid endarterectomy SNOMED-CT Hospital Data Project WHO
0-L 38102005 Cholecystectomy SNOMED-CT Hospital Data Project WHO Excision of all or part of the gallbladder
0-L 3418002 Chondrectomy of spine SNOMED-CT Hospital Data Project WHO
0-L 23968004 Colectomy SNOMED-CT Hospital Data Project WHO
0-L 73761001 Colonoscopy SNOMED-CT Hospital Data Project WHO
0-L 4770005 Colporrhaphy for repair of urethrocele SNOMED-CT TOP 20 Germany
0-L 63016009 Complete cystectomy SNOMED-CT TOP 20 Germany
0-L 232717009 Coronary artery bypass graft SNOMED-CT Hospital Data Project WHO
0-L 312775003 Debridement of ulcer SNOMED-CT TOP 20 Germany
0-L 47534009 Decompression of median nerve SNOMED-CT Hospital Data Project WHO The surgical relief of compression of the median nerve at the wrist
0-L 76810006 Diagnostic dilation and curettage of uterus SNOMED-CT Hospital Data Project WHO A form carried out to examine the removed uterine contents for disease characteristics
0-L 423827005 Endoscopy SNOMED-CT
0-L 85548006 Episiotomy SNOMED-CT TOP 20 Germany
0-L 9888007 Excision of intracranial lesion SNOMED-CT Hospital Data Project WHO
0-L 370611004 Excision of malignant neoplasm SNOMED-CT
0-L 56361007 Excision of soft tissue SNOMED-CT
0-L 257822003 Extracapsular extraction SNOMED-CT Hospital Data Project WHO
0-L 54885007 Extraction of cataract SNOMED-CT Hospital Data Project WHO
0-L 112828007 Femoral-popliteal artery bypass graft SNOMED-CT Hospital Data Project WHO
0-L 236886002 Hysterectomy SNOMED-CT TOP 20 Germany
0-L 359612003 Implantation of cochlear prosthetic device SNOMED-CT Hospital Data Project WHO
0-L 64253000 Implantation of heart assist system SNOMED-CT
0-L 118955007 Implantation to cardiovascular system SNOMED-CT
0-L 426153007 Insertion of artificial airway SNOMED-CT
0-L 302343007 Insertion of prosthesis for breast SNOMED-CT
0-L 265703000 Jaw and temporomandibular joint operations SNOMED-CT
0-L 45595009 Laparoscopic cholecystectomy SNOMED-CT Hospital Data Project WHO
0-L 236887006 Laparoscopic hysterectomy SNOMED-CT TOP 20 Germany
0-L 15018006 Laparoscopic repair of inguinal hernia SNOMED-CT Hospital Data Project WHO
0-L 363187007 Limb operation SNOMED-CT Czech EDS
0-L 133864008 Lithotripsy SNOMED-CT
0-L 173171007 Lobectomy of lung SNOMED-CT Hospital Data Project WHO
0-L 386638009 Obstetric operation SNOMED-CT
0-L 21371007 Operation on abdominal region SNOMED-CT Czech EDS
0-L 57168000 Operation on bone SNOMED-CT Czech EDS
0-L 392090004 Operation on breast SNOMED-CT
0-L 26476002 Operation on bronchus SNOMED-CT
0-L 53266006 Operation on diaphragm SNOMED-CT
0-L 12658000 Operation on female genital organs SNOMED-CT Czech EDS
0-L 78418002 Operation on heart and pericardium SNOMED-CT
0-L 112698002 Operation on joint SNOMED-CT Czech EDS
0-L 387714009 Operation on lung SNOMED-CT
0-L 49509003 Operation on lymphatic structure SNOMED-CT
0-L 386765006 Operation on mediastinum SNOMED-CT
0-L 37508003 Operation on neck SNOMED-CT Czech EDS
0-L 16545005 Operation on nervous system SNOMED-CT Czech EDS
0-L 34969007 Operation on retroperitoneum SNOMED-CT
0-L 392011001 Operation on skin SNOMED-CT
0-L 59300005 Operation on spleen SNOMED-CT
0-L 86800006 Operation on trachea SNOMED-CT
0-L 392048005 Operation on urinary system SNOMED-CT Czech EDS
0-L 107907001 Operative procedure on digestive system SNOMED-CT
0-L 108021004 Operative procedure on male genitourinary system SNOMED-CT
0-L 392236004 Operative procedure on spinal structure SNOMED-CT Czech EDS
0-L 36228007 Ophthalmic examination and evaluation SNOMED-CT
0-L 64368001 Partial mastectomy SNOMED-CT Hospital Data Project WHO
0-L 429639007 Percutaneous transluminal balloon angioplasty with insertion of stent into coronary artery SNOMED-CT Hospital Data Project WHO
0-L 118804001 Procedure on blood vessel SNOMED-CT TOP 20 Germany
0-L 118683007 Procedure on ear and related structures SNOMED-CT
0-L 118949002 Procedure on extremity SNOMED-CT
0-L 118675001 Procedure on female genital system SNOMED-CT
0-L 118716003 Procedure on foot SNOMED-CT TOP 20 Germany
0-L 118950002 Procedure on head AND/OR neck SNOMED-CT
0-L 118831003 Procedure on intestine SNOMED-CT TOP 20 Germany
0-L 118795000 Procedure on pleura SNOMED-CT
0-L 90470006 Prostatectomy SNOMED-CT Hospital Data Project WHO
0-L 397956004 Prosthetic arthroplasty of the hip SNOMED-CT Hospital Data Project WHO
0-L 85921004 Puncture procedure SNOMED-CT
0-L 384723003 Radical mastectomy SNOMED-CT Hospital Data Project WHO
0-L 122470005 Reduction of closed fracture SNOMED-CT TOP 20 Germany
0-L 122471009 Reduction of open fracture SNOMED-CT TOP 20 Germany
0-L 405525004 Repair of aneurysm of abdominal aorta SNOMED-CT Hospital Data Project WHO
0-L 441612006 Repair of infrarenal abdominal aortic aneurysm with insertion of endovascular stent SNOMED-CT Hospital Data Project WHO
0-L 44558001 Repair of inguinal hernia SNOMED-CT Hospital Data Project WHO
0-L 112727005 Revision of hip replacement SNOMED-CT Hospital Data Project WHO
0-L 86749008 Stripping and ligation SNOMED-CT TOP 20 Germany
0-L 70183006 Subcutaneous mastectomy SNOMED-CT Hospital Data Project WHO
0-L 385488000 Surgical procedure on chest wall SNOMED-CT
0-L 373353005 Surgical procedure on eye proper SNOMED-CT Czech EDS
0-L 385487005 Surgical procedure on thorax SNOMED-CT Czech EDS
0-L 13619001 Thyroidectomy SNOMED-CT
0-L 173422009 Tonsillectomy SNOMED-CT Hospital Data Project WHO
0-L 359623004 Total lobectomy of lung SNOMED-CT Hospital Data Project WHO
0-L 70536003 Transplant of kidney SNOMED-CT Hospital Data Project WHO
0-L 90199006 Transurethral prostatectomy SNOMED-CT Hospital Data Project WHO
0-L 30904006 Vascular surgery procedure SNOMED-CT Czech EDS
0-L 232632009 Wedge excision of lung SNOMED-CT Hospital Data Project WHO
0-L 80146002 Appendicectomy SNOMED-CT Hospital Data Project WHO
0-L 11466000 Caesarean section SNOMED-CT Hospital Data Project WHO
0-L 10458001 Evacuation of intracerebral haematoma SNOMED-CT Hospital Data Project WHO
0-L 59712006 Evacuation of subdural haematoma SNOMED-CT Hospital Data Project WHO
0-L 46116005 Excision of malignant tumour of breast SNOMED-CT
0-L 234336002 Haemopoietic stem cell transplant SNOMED-CT Hospital Data Project WHO
0-L 6025007 Laparoscopic appendicectomy SNOMED-CT Hospital Data Project WHO
0-L 287310004 Lung tumour excision SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:31:51
  Author assigned by Alexander Henket (id#4)
  Description Is obtaining this code still relevant
tracking Tracking 2013‑06‑09 - status: Open
  Author Alexander Henket
Description Issue:

Should add laparoscopic colectomy. Currently no good code was identified

Additional info:

Hospital Data Project WHO

 (epsos-issue-24) Value set epSOSCodeProb without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.24)
Last assignment to Giorgio Cangioli

Issue Value set epSOSCodeProb without dataset binding
Id epsos-issue-24
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-23 (2013‑06‑03)
Description
The Value Set is used as an optional description of a problem in the patient Summary. It gives an information on the circumstances under which the problem was defined/discovered.
Value Set Name Value Set Id Version / effective date Status
epSOSCodeProb 1.3.6.1.4.1.12559.11.10.1.3.1.42.23 July 2009 - 2013‑06‑03 Draft
notice There is an open issue with this item:
  • epsos-issue-24: Value set epSOSCodeProb without dataset binding (Open)
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 404684003 Clinical finding SNOMED-CT
0-L 409586006 Complaint SNOMED-CT
0-L 282291009 Diagnosis interpretation SNOMED-CT
0-L 64572001 Disease SNOMED-CT
0-L 248536006 Finding of functional performance and activity SNOMED-CT
0-L 418799008 Finding reported by subject or history provider SNOMED-CT
0-L 55607006 Problem SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:07:01
  Author assigned by Alexander Henket (id#4)
  Description It does not map to the Problem Code, this is already bound to epSOSIllnessesAndDisorders, but it still appears to be the most likely candidate
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-37) Value set epSOSDisplayLabel without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.37)
Last assignment to Giorgio Cangioli

Issue Value set epSOSDisplayLabel without dataset binding
Id epsos-issue-37
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-46 (2013‑06‑03)
Description
The Value Set is used to denominate all the labels and messages adopted for the epSOS CDA display
Value Set Name Value Set Id Version / effective date Status
epSOSDisplayLabel 1.3.6.1.4.1.12559.11.10.1.3.1.42.46 2013‑06‑03 Draft
notice There is an open issue with this item:
  • epsos-issue-37: Value set epSOSDisplayLabel without dataset binding (Open)
Source Code System:
  • 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 epSOSDisplayLabel
Level/ Type Code Display Name Code System Description
0-L 1 Active Ingredient epSOSDisplayLabel
0-L 10 Clinical Manifestation epSOSDisplayLabel
0-L 107 I confirm that the patient –data subject has consented to the following statement: ‘I agree that my Patient Summary may be transferred to a registered Health Professional in [COUNTRY B] for the purposes of providing me with medical care and/or medication’ epSOSDisplayLabel
0-L 11 Closed/Inactive Problem epSOSDisplayLabel
0-L 12 Contact Information epSOSDisplayLabel
0-L 13 Country epSOSDisplayLabel
0-L 14 Country A Medicinal Product Code epSOSDisplayLabel
0-L 15 Creation Date epSOSDisplayLabel
0-L 16 Custodian epSOSDisplayLabel
0-L 17 Date epSOSDisplayLabel
0-L 18 Date To epSOSDisplayLabel
0-L 19 Date of Birth epSOSDisplayLabel
0-L 2 Active Problem epSOSDisplayLabel
0-L 20 Date of Prescription epSOSDisplayLabel
0-L 21 Device/Implant epSOSDisplayLabel
0-L 22 Dispense epSOSDisplayLabel
0-L 23 Dispensed Package Size epSOSDisplayLabel
0-L 24 Dispensed Product epSOSDisplayLabel
0-L 25 Dose Form epSOSDisplayLabel
0-L 26 End Date epSOSDisplayLabel
0-L 27 Every epSOSDisplayLabel
0-L 28 Facility ID epSOSDisplayLabel
0-L 29 Facility Name epSOSDisplayLabel
0-L 3 Address epSOSDisplayLabel
0-L 30 Family Name epSOSDisplayLabel
0-L 31 for epSOSDisplayLabel
0-L 32 Frequency of Intakes epSOSDisplayLabel
0-L 33 Gender epSOSDisplayLabel
0-L 34 Given Name epSOSDisplayLabel
0-L 35 Guardian epSOSDisplayLabel
0-L 36 Implant Date epSOSDisplayLabel
0-L 37 Instructions to patient epSOSDisplayLabel
0-L 38 Is substitution of brand name allowed? epSOSDisplayLabel
0-L 39 Last Update epSOSDisplayLabel
0-L 4 Advise to the dispenser epSOSDisplayLabel
0-L 40 Legal Authenticator epSOSDisplayLabel
0-L 41 National Insurance Number epSOSDisplayLabel
0-L 42 No epSOSDisplayLabel
0-L 43 Number of packages epSOSDisplayLabel
0-L 44 Observation Type epSOSDisplayLabel
0-L 45 Onset Date epSOSDisplayLabel
0-L 46 Organisation Identifier epSOSDisplayLabel
0-L 47 Organisation Name epSOSDisplayLabel
0-L 48 Other Active Ingredients epSOSDisplayLabel
0-L 49 Other Contacts epSOSDisplayLabel
0-L 5 Agent epSOSDisplayLabel
0-L 50 Package Size epSOSDisplayLabel
0-L 51 Patient epSOSDisplayLabel
0-L 52 Patient IDs epSOSDisplayLabel
0-L 53 per unit epSOSDisplayLabel
0-L 54 Preferred HP/Legal organization to contact epSOSDisplayLabel
0-L 55 Prefix epSOSDisplayLabel
0-L 56 Prescriber epSOSDisplayLabel
0-L 57 Prescriber details epSOSDisplayLabel
0-L 58 Prescription ID epSOSDisplayLabel
0-L 59 Prescription Item Details epSOSDisplayLabel
0-L 6 at epSOSDisplayLabel
0-L 60 Prescription Item ID epSOSDisplayLabel
0-L 61 Prescription Items List epSOSDisplayLabel
0-L 62 Procedure epSOSDisplayLabel
0-L 63 Procedure Date epSOSDisplayLabel
0-L 64 Profession epSOSDisplayLabel
0-L 65 Reaction Type epSOSDisplayLabel
0-L 66 Regional/National Health ID epSOSDisplayLabel
0-L 67 Route of Administration epSOSDisplayLabel
0-L 68 See details epSOSDisplayLabel
0-L 69 Specialty epSOSDisplayLabel
0-L 7 Author (HP) epSOSDisplayLabel
0-L 70 Strength epSOSDisplayLabel
0-L 71 Substitute epSOSDisplayLabel
0-L 72 The Active Problem section is missing ! epSOSDisplayLabel
0-L 73 The Allergies, adverse reactions, alerts section is missing ! epSOSDisplayLabel
0-L 74 The Medical Devices and implants section is missing ! epSOSDisplayLabel
0-L 75 The Medication Summary section is missing ! epSOSDisplayLabel
0-L 76 The History of Procedures section is missing ! epSOSDisplayLabel
0-L 77 unit(s) epSOSDisplayLabel
0-L 78 Units per intake epSOSDisplayLabel
0-L 79 Vaccination epSOSDisplayLabel
0-L 8 Authoring Device epSOSDisplayLabel
0-L 80 Vaccination Date epSOSDisplayLabel
0-L 81 Yes epSOSDisplayLabel
0-L 82 I have identified the patient-data subject epSOSDisplayLabel
0-L 83 I confirm that the patient –data subject has consented to the following statement: ‘I agree that my ePrescription may be transferred to a registered Health Professional in [COUNTRY B] for the purposes of providing me with medical care and/or medication’ epSOSDisplayLabel
0-L 84 Observation Value epSOSDisplayLabel
0-L 85 Date From epSOSDisplayLabel
0-L 9 Brand Name epSOSDisplayLabel
0-L 99 Physical Findings epSOSDisplayLabel
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:43:45
  Author assigned by Alexander Henket (id#4)
  Description This means we do not use in our specification at all and can remove it from ART-DECOR?
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:40:12
  Author assigned by Giorgio Cangioli (id#5)
  Description this value set is used for the display system. There are no bindings with the CDA elements
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-31) Value set epSOSPersonalRelationship without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.31)
Last assignment to Giorgio Cangioli

Issue Value set epSOSPersonalRelationship without dataset binding
Id epsos-issue-31
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-38 (2013‑06‑03)
Description
The Value Set is used (optionally) to code the type of contact relationship between a person and the patient.
Value Set Name Value Set Id Version / effective date Status
epSOSPersonalRelationship 1.3.6.1.4.1.12559.11.10.1.3.1.42.38 913-20091020 - 2013‑06‑03 Draft
notice There is an open issue with this item:
  • epsos-issue-31: Value set epSOSPersonalRelationship without dataset binding (Open)
Source Code System:
  • 2.16.840.1.113883.5.111 RoleCode
Level/ Type Code Display Name Code System Description
0-L AUNT aunt RoleCode
0-L CHILD child RoleCode
0-L CHLDADOPT adopted child RoleCode
0-L CHLDFOST foster child RoleCode
0-L CHLDINLAW child in-law RoleCode
0-L COUSN cousin RoleCode
0-L DAU natural daughter RoleCode
0-L DAUADOPT adopted daughter RoleCode
0-L DAUC daughter RoleCode
0-L DAUFOST foster daughter RoleCode
0-L DAUINLAW daughter in-law RoleCode
0-L DOMPART domestic partner RoleCode
0-L FAMMEMB family member RoleCode
0-L FRND unrelated friend RoleCode
0-L FTH father RoleCode
0-L FTHINLAW father-in-law RoleCode
0-L GGRPRN great grandparent RoleCode
0-L GRNDCHILD grandchild RoleCode
0-L GRPRN grandparent RoleCode
0-L MTH mother RoleCode
0-L MTHINLAW mother-in-law RoleCode
0-L NBOR neighbor RoleCode
0-L NCHILD natural child RoleCode
0-L NIENEPH niece/nephew RoleCode
0-L PRN parent RoleCode
0-L PRNINLAW parent in-law RoleCode
0-L ROOM roomate RoleCode
0-L SIB sibling RoleCode
0-L SIGOTHR significant other RoleCode
0-L SON natural son RoleCode
0-L SONADOPT adopted son RoleCode
0-L SONC son RoleCode
0-L SONFOST foster son RoleCode
0-L SONINLAW son in-law RoleCode
0-L SPS spouse RoleCode
0-L STPCHLD step child RoleCode
0-L STPDAU stepdaughter RoleCode
0-L STPSON stepson RoleCode
0-L UNCLE uncle RoleCode
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:20:28
  Author assigned by Alexander Henket (id#4)
  Description The only element that comes close is "The role of the person: contact person or legal guardian", but as it says in the description that needs two concepts that are not intrinsically part of this PersonalRelationship value set. My fear is that we're somehow missing something in the dataset
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-32) Value set epSOSRoleClass without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.32)
Last assignment to Giorgio Cangioli

Issue Value set epSOSRoleClass without dataset binding
Id epsos-issue-32
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-39 (2013‑06‑03)
Description
The Value Set is used to make the distinction between an emergency contact and the next of kin for a patient.
Value Set Name Value Set Id Version / effective date Status
epSOSRoleClass 1.3.6.1.4.1.12559.11.10.1.3.1.42.39 913-20091020 - 2013‑06‑03 Draft
notice There are open issues with this item:
  • epsos-issue-32: Value set epSOSRoleClass without dataset binding (Open)
  • epsos-issue-38: Two different descriptions in the documentation (Open)
Source Code System:
  • 2.16.840.1.113883.5.110 RoleClass
Level/ Type Code Display Name Code System Description
0-L ECON emergency contact RoleClass
0-L NOK next of kin RoleClass
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
Issue epsos-issue-38
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:27:44
  Author assigned by Alexander Henket (id#4)
  Description Comparable to issue#31 this appears to come close to "The role of the person: contact person or legal guardian", but misses Legal Guardian. It is just meant to support the CDA.participant.AssociatedEntity.classCode? If so then this is just conveyed at template level See also:

Issue#38 that deals with the same valueSet
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping. May be HL7 Template only?

 (epsos-issue-33) Value set epSOSTimingAddress without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.33)
Last assignment to Giorgio Cangioli

Issue Value set epSOSTimingAddress without dataset binding
Id epsos-issue-33
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-40 (2013‑06‑03)
Description
The Value Set is used (optionally) to code the usage of a phone number, email and all telecommunications. Can be used for all phone numbers mentioned in the three CDA-documents.
Value Set Name Value Set Id Version / effective date Status
epSOSTelecomAddress 1.3.6.1.4.1.12559.11.10.1.3.1.42.40 913-20091020 - 2013‑06‑03 Draft
notice There is an open issue with this item:
  • epsos-issue-33: Value set epSOSTimingAddress without dataset binding (Open)
Source Code System:
  • 2.16.840.1.113883.5.1119 AddressUse
Level/ Type Code Display Name Code System Description
0-L AS answering service AddressUse
0-L EC emergency contact AddressUse
0-L H home AddressUse
0-L HP primary home AddressUse
0-L HV vacation home AddressUse
0-L MC mobile contact AddressUse
0-L PG pager AddressUse
0-L WP work place AddressUse
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:29:01
  Author assigned by Alexander Henket (id#4)
  Description The dataset does not have any concept like Telecom type for example. Shouldn't we have that to support this?
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-38) Two different descriptions in the documentation
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.38)
Last assignment to Giorgio Cangioli

Issue Two different descriptions in the documentation
Id epsos-issue-38
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-39 (2013‑06‑03)
Description
The Value Set is used to make the distinction between an emergency contact and the next of kin for a patient.
Value Set Name Value Set Id Version / effective date Status
epSOSRoleClass 1.3.6.1.4.1.12559.11.10.1.3.1.42.39 913-20091020 - 2013‑06‑03 Draft
notice There are open issues with this item:
  • epsos-issue-32: Value set epSOSRoleClass without dataset binding (Open)
  • epsos-issue-38: Two different descriptions in the documentation (Open)
Source Code System:
  • 2.16.840.1.113883.5.110 RoleClass
Level/ Type Code Display Name Code System Description
0-L ECON emergency contact RoleClass
0-L NOK next of kin RoleClass
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
Issue Value set epSOSRoleClass without dataset binding epsos-issue-32
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑10 19:40:12
  Author assigned by Alexander Henket (id#4)
  Description Please respond in conjunction with issue#32. Thanks in advance
tracking Tracking 2013‑10‑18 15:46:48 - status: Open
  Author Tessa van Stijn
Description Issue:

- According to specifications at page 24 of the document "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" the value of /ClinicalDocument/participant/[@typeCode=’IND’]/associatedEntity/@classCode should come from valueset epSOSRoleClass 2.16.840.1.113883.5.110

The valueset epSOSRoleClass has the values: "ECON" and "NOK".

At page 84 of the same document there is different information:

"The <associatedEntity> element defines the type of contact. The classCode attribute shall be present, and contains a value from the set AGNT, CAREGIVER, ECON, NOK, or PRS to idenitify contacts that are agents of the patient, care givers, emergency contacts, next of kin, or other relations respectively."

Proposal:

- Please clarify which of these two descriptions is correct.

Should the valueset epSOSRoleClass be corrected to contain also the values AGNT, CAREGIVER and PRS or should the information at the page 84 be corrected (contains only the values ECON and NOK)?

See also:

Issue#32 that deals with the same valueSet

 (epsos-issue-39) Element Indication
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.39)
Last assignment to Giorgio Cangioli

Issue Element Indication
Id epsos-issue-39
Type Change Request
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-143 "Dispense" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication
folder  Dispense
Id epsos-dataelement-143
notice There are open issues with this item:
Description Information about dispensed medication
Used in 3 scenarios, inherited 0 times
target This concept is used in transaction Send eD to country A (0..*) in scenario
target This concept is used in transaction Return MRO (0..*) in scenario
target This concept is used in transaction Send HCER to country A (0..*) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:53:41
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑10‑18 15:50:15 - status: Open
  Author Tessa van Stijn
Description Issue:

- According to specifications at page 96 of the document "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf"

"D1 4 3 Specification of services v1 0 20120911 (2).pdf" the element Indication should be included in Medication.

In the document "D1 4 3 Specification of services v1 0 20120911 (2).pdf" the element Indication is not present.

Proposal:

- Please clarify if the element Indication should be included in Dispensation.

More info:

-

 (epsos-issue-42) Status
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.42)
Last assignment to Giorgio Cangioli

Issue Status
Id epsos-issue-42
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-101 "Medication" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data
folder  Medication
Id epsos-dataelement-101
notice There is an open issue with this item:
Description
Used in 5 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (0..1) in scenario
target This concept is used in transaction Send eD to country A (0..1) in scenario
target This concept is used in transaction Return MRO (0..1) in scenario
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 18:07:58
  Author assigned by Alexander Henket (id#4)
  Description The appendix recognizes a prescription status, but describes it as
(12.1.2.4.5.6. Substance Administration Status Code) "The status code of "active" indicates that the medication has not been yet administrated .", but also:
(12.1.1.2.4.4. Substance Administration Status Code) "The status of all <substanceAdministration> elements must be either "active" or "completed". Status of "active" indicates a currently valid prescription, status of completed indicates a previously taken medication."

However the dataset does not recognize a notion of Status on a prescription, so should it be added? Only on Prescription or also on Dispense?
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:37:13
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑11‑10 19:36:53 - status: Open
  Author Giorgio Cangioli
Description Not sure about the question...

In any case conceptually is requried to otionally provide patient instructiona and advice to the ispenser.

The template used for implementing this concept require to provide also the statusCode elemente with value completed....
tracking Tracking 2013‑10‑18 15:56:05 - status: Open
  Author Tessa van Stijn
Description Issue:

- According to the specifications at page 120 of the document

 "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" the Medication (element should include an element Status Code (if the related statement is made about the medication).

In the document "D1 4 3 Specification of services v1 0 20120911 (2).pdf" the element Status Code is not present.

Proposal:

-Please clarify if the element Status Code should be included.

More info:

-

 (epsos-issue-43) Name of the concept
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.43)
Last assignment to Giorgio Cangioli

Issue Name of the concept
Id epsos-issue-43
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-98 "Disability or function" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medical Problems
folder  Disability or function
Id epsos-dataelement-98
notice There is an open issue with this item:
Description
Used in 3 scenarios, inherited 0 times
target This concept is used in transaction Return MRO (0..*) in scenario
target This concept is used in transaction Send HCER to country A (0..*) in scenario
target This concept is used in transaction Return PS of country A (0..*) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 18:09:16
  Author assigned by Alexander Henket (id#4)
  Description Can we close this one without action based on the fact that Invalidity is not actually used in epSOS, but just kept in the dataset for historical reasons? The concept is not in the scenarios anymore.
tracking Tracking 2013‑10‑21 11:53:43 - status: Open
  Author Elze de Groot
Description Name of the concept: Autonomy/invalidity (MRO) vs Disability or function (HCER)

 (epsos-issue-47) Missing value set binding for Health Care Alert code
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.47)
Last assignment to Giorgio Cangioli

Issue Missing value set binding for Health Care Alert code
Id epsos-issue-47
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-216 "Health Care Alert code" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Alerts / Medical Alert Information
Health Care Alert code
Id epsos-dataelement-216
notice There is an open issue with this item:
  • epsos-issue-47: Missing value set binding for Health Care Alert code (Open)
Description The code of the health care alert
Value Domain Type code
Used in one scenario, inherited 0 times
target This concept is used in transaction Return PS of country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:32:12
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑11‑29 10:37:10 - status: Open
  Author Alexander Henket
Description Finding:

The documentation is undecided as to what value set binding is applicable. Also it would appear that "Other alerts" is not part of epSOS-I in which case we would need to detach from the PS it is currently attached to.

 (epsos-issue-48) Missing value set binding for Treatment code
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.48)
Last assignment to Giorgio Cangioli

Issue Missing value set binding for Treatment code
Id epsos-issue-48
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-130 "Treatment code" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medical Problems / Treatments
Treatment code
Id epsos-dataelement-130
notice There is an open issue with this item:
Description normalized identifier, concept code
Value Domain Type code
Used in 2 scenarios, inherited 0 times
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:32:28
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑11‑29 10:37:10 - status: Open
  Author Alexander Henket
Description Finding:

The documentation is undecided as to what value set binding is applicable.

 (epsos-issue-49) Missing value set binding for Prescriber Speciality
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.49)
Last assignment to Giorgio Cangioli

Issue Missing value set binding for Prescriber Speciality
Id epsos-issue-49
Type Change Request
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-238 "Prescriber Speciality" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication / Prescription / Prescriber
Prescriber Speciality
Id epsos-dataelement-238
notice There is an open issue with this item:
  • epsos-issue-49: Missing value set binding for Prescriber Speciality (Open)
Description Some countries need the specialty of the prescriber for the epSOS ePrescription to be seen as valid. In the epSOS phase 1 ePrescription data set, this element is not basic (minimum), therefore not always filled in. The proposal is to define the specialty of the prescriber as a basic element, so it should be filled in, if available. As it could be that this information is not available in every country, null values should be allowed.
Value Domain Type code
Used in 4 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (0..*) in scenario
target This concept is used in transaction Return MRO (0..1) in scenario
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:32:42
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑11‑29 10:56:53 - status: Open
  Author Alexander Henket
Description Finding:

The documentation is undecided as to what value set binding is applicable.

 (epsos-issue-50) Missing concepts for Dispenser?
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.50)
Last assignment to Giorgio Cangioli

Issue Missing concepts for Dispenser?
Id epsos-issue-50
Type Change Request
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-247 "Dispenser" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication / Dispense
folder  Dispenser
Id epsos-dataelement-247
notice There is an open issue with this item:
Description
Used in 3 scenarios, inherited 0 times
target This concept is used in transaction Send eD to country A (0..1) in scenario
target This concept is used in transaction Return MRO (0..1) in scenario
target This concept is used in transaction Send HCER to country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:32:58
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑11‑29 10:58:36 - status: Open
  Author Alexander Henket
Description Finding:

The dispenser documentation was not consistent with the prescriber. There is no Profession and no Speciality. Should there be?

 (epsos-issue-51) What is template "1.3.6.1.4.1.19376.1.5.3.1.2.4"
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.51)
Last assignment to Giorgio Cangioli

Issue What is template "1.3.6.1.4.1.19376.1.5.3.1.2.4"
Id epsos-issue-51
Type Change Request
Status  Open, assigned
Priority normal
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:33:12
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑12‑02 13:23:23 - status: Open
  Author Alexander Henket
Description

 (epsos-issue-52) Cardinality/nullFlavor for address (parts)
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.52)
Last assignment to Giorgio Cangioli

Issue Cardinality/nullFlavor for address (parts)
Id epsos-issue-52
Type Change Request
Status  Open, assigned
Priority normal
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:33:24
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑12‑02 13:31:47 - status: Open
  Author Alexander Henket
Description

In "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" it would appear that addresses are overstated and suffer from some copy/paste problems. You are currently required to either state no address parts or every single mentioned address part with either a value or a nullFlavor (not stated which nullFlavor). Also every address part may appear 1..* R, including city, state, and country. This leads to fragments like:

         <addr use="H">
            <state nullFlavor="NI"/>
            <city>MILANO</city>
            <country>IT</country>
            <state>ZH</state>
            <city>ROTTERDAM</city>
            <country>NL</country>
            <postalCode nullFlavor="UNK"/>
         </addr>

I.e. multiple types of NULL and multiple colliding address parts. What is the reason behind this? Any addr specification we have encountered in any context has said that unknown address(parts/es) should just be omitted, and with the exception of streetAddressLine no other parts should be use more than once.

 (epsos-issue-53) HP can have only 1 relevant speciality in a given context
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.53)
Last assignment to Giorgio Cangioli

Issue HP can have only 1 relevant speciality in a given context
Id epsos-issue-53
Type Change Request
Status  Open, assigned
Priority normal
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 14:05:26
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑12‑02 14:05:10 - status: Open
  Author Alexander Henket
Description Requirement 1.10.7 in "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" has card 0..*. This is not possible. It must be 0..1. Also the description of that specialty should be something like "the relevant speciality of the HP in relation to this serviceEvent or when authoring the document." Any given HP may have multiple specialities, but only 1 is relevant given the context.

Issues not yet assigned

Issues dealt with

 (epsos-issue-10) Value set epSOSHealthcareProfessionalRoles without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.10)
Not assigned yet.

Issue Value set epSOSHealthcareProfessionalRoles without dataset binding
Id epsos-issue-10
Type Clarification needed
Status  Closed
Priority normal
Object(s) Value set epsos-valueset-1 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSHealthcareProfessionalRoles 1.3.6.1.4.1.12559.11.10.1.3.1.42.1 2008 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.2.9.6.2.7 ISCO
Level/ Type Code Display Name Code System Description
0-L 22 Health professionals ISCO
0-L 221 Medical doctors ISCO
0-L 2211 Generalist medical practitioners ISCO
0-L 2212 Specialist medical practitioners ISCO
0-L 222 Nursing and midwifery professionals ISCO
0-L 2221 Nursing professionals ISCO
0-L 2222 Midwifery professionals ISCO
0-L 223 Traditional and complementary medicine professionals ISCO
0-L 224 Paramedical practitioners ISCO
0-L 225 Veterinarians ISCO
0-L 226 Other health professionals ISCO
0-L 2261 Dentists ISCO
0-L 2262 Pharmacists ISCO
0-L 2263 Environmental and occupational health and hygiene professionals ISCO
0-L 2264 Physiotherapists ISCO
0-L 2265 Dieticians and nutritionists ISCO
0-L 2266 Audiologists and speech therapists ISCO
0-L 2267 Optometrists and ophthalmic opticians ISCO
0-L 2269 Health professionals not elsewhere classified ISCO
0-L 32 Health associate professionals ISCO
0-L 321 Medical and pharmaceutical technicians ISCO
0-L 3211 Medical imaging and therapeutic equipment technicians ISCO
0-L 3212 Medical and pathology laboratory technicians ISCO
0-L 3213 Pharmaceutical technicians and assistants ISCO
0-L 3214 Medical and dental prosthetic technicians ISCO
0-L 322 Nursing and midwifery associate professionals ISCO
0-L 3221 Nursing associate professionals ISCO
0-L 3222 Midwifery associate professionals ISCO
0-L 323 Traditional and complementary medicine associate professionals ISCO
0-L 325 Other health associate professionals ISCO
0-L 3251 Dental assistants and therapists ISCO
0-L 3252 Medical records and health information technicians ISCO
0-L 3253 Community health workers ISCO
0-L 3254 Dispensing opticians ISCO
0-L 3255 Physiotherapy technicians and assistants ISCO
0-L 3256 Medical assistants ISCO
0-L 3257 Environmental and occupational health inspectors and associates ISCO
0-L 3258 Ambulance workers ISCO
0-L 3259 Health associate professionals not elsewhere classified ISCO
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑10‑22 15:28:33 - status: Closed
  Author Elze de Groot
Description Binded to healthcare professional roles in legal entity
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-1) Add Thyroidectomy, Partial and Total
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.1)
Last assignment to Alexander Henket

Issue Add Thyroidectomy, Partial and Total
Id epsos-issue-1
Type Change Request
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-10 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSProcedures 1.3.6.1.4.1.12559.11.10.1.3.1.42.10 July 2009 - 2013‑06‑03 Draft
notice There are open issues with this item:
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 19063003 Arthroplasty of knee SNOMED-CT Hospital Data Project WHO
0-L 84877006 Arthroscopy of knee with meniscus repair SNOMED-CT TOP 20 Germany
0-L 119922005 Biliary tract endoscopy SNOMED-CT TOP 20 Germany
0-L 86273004 Biopsy SNOMED-CT
0-L 10847001 Bronchoscopy SNOMED-CT Hospital Data Project WHO
0-L 112802009 Cardiovascular surgical procedure SNOMED-CT
0-L 250980009 Cardioversion SNOMED-CT
0-L 66951008 Carotid endarterectomy SNOMED-CT Hospital Data Project WHO
0-L 38102005 Cholecystectomy SNOMED-CT Hospital Data Project WHO Excision of all or part of the gallbladder
0-L 3418002 Chondrectomy of spine SNOMED-CT Hospital Data Project WHO
0-L 23968004 Colectomy SNOMED-CT Hospital Data Project WHO
0-L 73761001 Colonoscopy SNOMED-CT Hospital Data Project WHO
0-L 4770005 Colporrhaphy for repair of urethrocele SNOMED-CT TOP 20 Germany
0-L 63016009 Complete cystectomy SNOMED-CT TOP 20 Germany
0-L 232717009 Coronary artery bypass graft SNOMED-CT Hospital Data Project WHO
0-L 312775003 Debridement of ulcer SNOMED-CT TOP 20 Germany
0-L 47534009 Decompression of median nerve SNOMED-CT Hospital Data Project WHO The surgical relief of compression of the median nerve at the wrist
0-L 76810006 Diagnostic dilation and curettage of uterus SNOMED-CT Hospital Data Project WHO A form carried out to examine the removed uterine contents for disease characteristics
0-L 423827005 Endoscopy SNOMED-CT
0-L 85548006 Episiotomy SNOMED-CT TOP 20 Germany
0-L 9888007 Excision of intracranial lesion SNOMED-CT Hospital Data Project WHO
0-L 370611004 Excision of malignant neoplasm SNOMED-CT
0-L 56361007 Excision of soft tissue SNOMED-CT
0-L 257822003 Extracapsular extraction SNOMED-CT Hospital Data Project WHO
0-L 54885007 Extraction of cataract SNOMED-CT Hospital Data Project WHO
0-L 112828007 Femoral-popliteal artery bypass graft SNOMED-CT Hospital Data Project WHO
0-L 236886002 Hysterectomy SNOMED-CT TOP 20 Germany
0-L 359612003 Implantation of cochlear prosthetic device SNOMED-CT Hospital Data Project WHO
0-L 64253000 Implantation of heart assist system SNOMED-CT
0-L 118955007 Implantation to cardiovascular system SNOMED-CT
0-L 426153007 Insertion of artificial airway SNOMED-CT
0-L 302343007 Insertion of prosthesis for breast SNOMED-CT
0-L 265703000 Jaw and temporomandibular joint operations SNOMED-CT
0-L 45595009 Laparoscopic cholecystectomy SNOMED-CT Hospital Data Project WHO
0-L 236887006 Laparoscopic hysterectomy SNOMED-CT TOP 20 Germany
0-L 15018006 Laparoscopic repair of inguinal hernia SNOMED-CT Hospital Data Project WHO
0-L 363187007 Limb operation SNOMED-CT Czech EDS
0-L 133864008 Lithotripsy SNOMED-CT
0-L 173171007 Lobectomy of lung SNOMED-CT Hospital Data Project WHO
0-L 386638009 Obstetric operation SNOMED-CT
0-L 21371007 Operation on abdominal region SNOMED-CT Czech EDS
0-L 57168000 Operation on bone SNOMED-CT Czech EDS
0-L 392090004 Operation on breast SNOMED-CT
0-L 26476002 Operation on bronchus SNOMED-CT
0-L 53266006 Operation on diaphragm SNOMED-CT
0-L 12658000 Operation on female genital organs SNOMED-CT Czech EDS
0-L 78418002 Operation on heart and pericardium SNOMED-CT
0-L 112698002 Operation on joint SNOMED-CT Czech EDS
0-L 387714009 Operation on lung SNOMED-CT
0-L 49509003 Operation on lymphatic structure SNOMED-CT
0-L 386765006 Operation on mediastinum SNOMED-CT
0-L 37508003 Operation on neck SNOMED-CT Czech EDS
0-L 16545005 Operation on nervous system SNOMED-CT Czech EDS
0-L 34969007 Operation on retroperitoneum SNOMED-CT
0-L 392011001 Operation on skin SNOMED-CT
0-L 59300005 Operation on spleen SNOMED-CT
0-L 86800006 Operation on trachea SNOMED-CT
0-L 392048005 Operation on urinary system SNOMED-CT Czech EDS
0-L 107907001 Operative procedure on digestive system SNOMED-CT
0-L 108021004 Operative procedure on male genitourinary system SNOMED-CT
0-L 392236004 Operative procedure on spinal structure SNOMED-CT Czech EDS
0-L 36228007 Ophthalmic examination and evaluation SNOMED-CT
0-L 64368001 Partial mastectomy SNOMED-CT Hospital Data Project WHO
0-L 429639007 Percutaneous transluminal balloon angioplasty with insertion of stent into coronary artery SNOMED-CT Hospital Data Project WHO
0-L 118804001 Procedure on blood vessel SNOMED-CT TOP 20 Germany
0-L 118683007 Procedure on ear and related structures SNOMED-CT
0-L 118949002 Procedure on extremity SNOMED-CT
0-L 118675001 Procedure on female genital system SNOMED-CT
0-L 118716003 Procedure on foot SNOMED-CT TOP 20 Germany
0-L 118950002 Procedure on head AND/OR neck SNOMED-CT
0-L 118831003 Procedure on intestine SNOMED-CT TOP 20 Germany
0-L 118795000 Procedure on pleura SNOMED-CT
0-L 90470006 Prostatectomy SNOMED-CT Hospital Data Project WHO
0-L 397956004 Prosthetic arthroplasty of the hip SNOMED-CT Hospital Data Project WHO
0-L 85921004 Puncture procedure SNOMED-CT
0-L 384723003 Radical mastectomy SNOMED-CT Hospital Data Project WHO
0-L 122470005 Reduction of closed fracture SNOMED-CT TOP 20 Germany
0-L 122471009 Reduction of open fracture SNOMED-CT TOP 20 Germany
0-L 405525004 Repair of aneurysm of abdominal aorta SNOMED-CT Hospital Data Project WHO
0-L 441612006 Repair of infrarenal abdominal aortic aneurysm with insertion of endovascular stent SNOMED-CT Hospital Data Project WHO
0-L 44558001 Repair of inguinal hernia SNOMED-CT Hospital Data Project WHO
0-L 112727005 Revision of hip replacement SNOMED-CT Hospital Data Project WHO
0-L 86749008 Stripping and ligation SNOMED-CT TOP 20 Germany
0-L 70183006 Subcutaneous mastectomy SNOMED-CT Hospital Data Project WHO
0-L 385488000 Surgical procedure on chest wall SNOMED-CT
0-L 373353005 Surgical procedure on eye proper SNOMED-CT Czech EDS
0-L 385487005 Surgical procedure on thorax SNOMED-CT Czech EDS
0-L 13619001 Thyroidectomy SNOMED-CT
0-L 173422009 Tonsillectomy SNOMED-CT Hospital Data Project WHO
0-L 359623004 Total lobectomy of lung SNOMED-CT Hospital Data Project WHO
0-L 70536003 Transplant of kidney SNOMED-CT Hospital Data Project WHO
0-L 90199006 Transurethral prostatectomy SNOMED-CT Hospital Data Project WHO
0-L 30904006 Vascular surgery procedure SNOMED-CT Czech EDS
0-L 232632009 Wedge excision of lung SNOMED-CT Hospital Data Project WHO
0-L 80146002 Appendicectomy SNOMED-CT Hospital Data Project WHO
0-L 11466000 Caesarean section SNOMED-CT Hospital Data Project WHO
0-L 10458001 Evacuation of intracerebral haematoma SNOMED-CT Hospital Data Project WHO
0-L 59712006 Evacuation of subdural haematoma SNOMED-CT Hospital Data Project WHO
0-L 46116005 Excision of malignant tumour of breast SNOMED-CT
0-L 234336002 Haemopoietic stem cell transplant SNOMED-CT Hospital Data Project WHO
0-L 6025007 Laparoscopic appendicectomy SNOMED-CT Hospital Data Project WHO
0-L 287310004 Lung tumour excision SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 14:35:23 - status: Closed
  Author Alexander Henket
Description Thyroidectomy = 13619001
arrowright Assignment to Alexander Henket (id#4) on 2013‑06‑11 14:59:14
  Author assigned by Alexander Henket (id#4)
  Description Find out the right code
tracking Tracking 2013‑06‑09 - status: Open
  Author Alexander Henket
Description Issue:

Should add "Thyroidectomy, Partial and Total". Currently 2 codes 171975009 or 13619001 are under consideration

Additional info:

Hospital Data Info Project WHO

 (epsos-issue-3) Add prefix/suffix to Full Name
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.3)
Not assigned yet.

Issue Add prefix/suffix to Full Name
Id epsos-issue-3
Type Change Request
Status  Closed
Priority normal
Object(s) Data element epsos-dataelement-9 "Full Name" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Patient Data / Personal Information
folder  Full Name
Id epsos-dataelement-9
Description The full name of the patient
Used in 5 scenarios, inherited 0 times
target This concept is used in transaction Request eP from country A (0..*) in scenario
target This concept is used in transaction Return eP from country A (1..1 Required) in scenario
target This concept is used in transaction Send eD to country A (1..1 Required) in scenario
target This concept is used in transaction Request MRO (0..*) in scenario
target This concept is used in transaction Return MRO (1..1 Required) in scenario
target This concept is used in transaction Send HCER to country A (1..1 Mandatory) in scenario
target This concept is used in transaction Request PS of country A (0..*) in scenario
target This concept is used in transaction Return PS of country A (1..1 Mandatory) in scenario
Data element epsos-dataelement-19 "Author Full Name" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Document Data / Author
folder  Author Full Name
Id epsos-dataelement-19
Description The full name of the Health Professional
Used in 5 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (1..1 Mandatory) in scenario
target This concept is used in transaction Send eD to country A (1..1 Mandatory) in scenario
target This concept is used in transaction Return MRO (1..1 Required) in scenario
target This concept is used in transaction Send HCER to country A (1..1 Required) in scenario
target This concept is used in transaction Return PS of country A (1..1 Mandatory) in scenario
Data element epsos-dataelement-46 "Full Name" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Patient Data / Contact Information / Preferred HP to contact
folder  Full Name
Id epsos-dataelement-46
Description Name of the HP/name of the legal organization. If it is an HP, the structure of the name will be the same as described in ‘Full name’ (Given name, family name/surname)
Used in 5 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (1..1 Mandatory) in scenario
target This concept is used in transaction Send eD to country A (1..1 Mandatory) in scenario
target This concept is used in transaction Return MRO (1..1 Mandatory) in scenario
target This concept is used in transaction Send HCER to country A (1..1 Required) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
Data element epsos-dataelement-36 "Full Name" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Patient Data / Contact Information / Contact Person/legal guardian
folder  Full Name
Id epsos-dataelement-36
Description Full name of the contact person or guardian
Used in 2 scenarios, inherited 0 times
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
tracking Tracking 2013‑11‑28 14:37:53 - status: Closed
  Author Alexander Henket
Description Prefix/suffix added to every Full Name
tracking Tracking 2013‑06‑09 23:22:32 - status: Open
  Author Alexander Henket
Description Issue:

Where the dataset has Full Name components "given" and "family name/surname", the PS recognizes at least "prefix" for patient, and for HPs also "suffix"

Proposal:

Find alignment. Adjust the dataset so it contains "prefix" for patients full name and "prefix" + "suffix" for HPs

 (epsos-issue-4) epSOS Active Ingredients: enumerate or not
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.4)
Last assignment to Alexander Henket

Issue epSOS Active Ingredients: enumerate or not
Id epsos-issue-4
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-24 (2013‑06‑03)
Description
The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.
Value Set Name Value Set Id Version / effective date Status
epSOSActiveIngredient 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 January 2010 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.73 WHO ATC
Level/ Type Code Display Name Code System Description
0-L A ALIMENTARY TRACT AND METABOLISM WHO ATC
0-L A01 STOMATOLOGICAL PREPARATIONS WHO ATC
0-L A01A STOMATOLOGICAL PREPARATIONS WHO ATC
0-L A01AA Caries prophylactic agents WHO ATC
0-L A01AA01 sodium fluoride WHO ATC
0-L A01AA02 sodium monofluorophosphate WHO ATC
0-L A01AA03 olaflur WHO ATC
0-L A01AA04 stannous fluoride WHO ATC
0-L A01AA30 combinations WHO ATC
0-L A01AA51 sodium fluoride, combinations WHO ATC
0-L A01AB Antiinfectives and antiseptics for local oral treatment WHO ATC
0-L A01AB02 hydrogen peroxide WHO ATC
0-L A01AB03 chlorhexidine WHO ATC
0-L A01AB04 amphotericin B WHO ATC
0-L A01AB05 polynoxylin WHO ATC
0-L A01AB06 domiphen WHO ATC
0-L A01AB07 oxyquinoline WHO ATC
0-L A01AB08 neomycin WHO ATC
0-L A01AB09 miconazole WHO ATC
0-L A01AB10 natamycin WHO ATC
0-L A01AB11 various WHO ATC
0-L A01AB12 hexetidine WHO ATC
0-L A01AB13 tetracycline WHO ATC
0-L A01AB14 benzoxonium chloride WHO ATC
0-L A01AB15 tibezonium iodide WHO ATC
0-L A01AB16 mepartricin WHO ATC
0-L A01AB17 metronidazole WHO ATC
0-L A01AB18 clotrimazole WHO ATC
0-L A01AB19 sodium perborate WHO ATC
0-L A01AB21 chlortetracycline WHO ATC
0-L A01AB22 doxycycline WHO ATC
0-L A01AB23 minocycline WHO ATC
0-L A01AC Corticosteroids for local oral treatment WHO ATC
0-L A01AC01 triamcinolone WHO ATC
0-L A01AC02 dexamethasone WHO ATC
0-L A01AC03 hydrocortisone WHO ATC
0-L A01AC54 prednisolone, combinations WHO ATC
0-L A01AD Other agents for local oral treatment WHO ATC
0-L A01AD01 epinephrine WHO ATC
0-L A01AD02 benzydamine WHO ATC
0-L A01AD05 acetylsalicylic acid WHO ATC
0-L A01AD06 adrenalone WHO ATC
0-L A01AD07 amlexanox WHO ATC
0-L A01AD08 becaplermin WHO ATC
0-L A01AD11 various WHO ATC
0-L A02 DRUGS FOR ACID RELATED DISORDERS WHO ATC
0-L A02A ANTACIDS WHO ATC
0-L A02AA Magnesium compounds WHO ATC
0-L A02AA01 magnesium carbonate WHO ATC
0-L A02AA02 magnesium oxide WHO ATC
0-L A02AA03 magnesium peroxide WHO ATC
0-L A02AA04 magnesium hydroxide WHO ATC
0-L A02AA05 magnesium silicate WHO ATC
0-L A02AA10 combinations WHO ATC
0-L A02AB Aluminium compounds WHO ATC
0-L A02AB01 aluminium hydroxide WHO ATC
0-L A02AB02 algeldrate WHO ATC
0-L A02AB03 aluminium phosphate WHO ATC
0-L A02AB04 dihydroxialumini sodium carbonate WHO ATC
0-L A02AB05 aluminium acetoacetate WHO ATC
0-L A02AB06 aloglutamol WHO ATC
0-L A02AB07 aluminium glycinate WHO ATC
0-L A02AB10 combinations WHO ATC
0-L A02AC Calcium compounds WHO ATC
0-L A02AC01 calcium carbonate WHO ATC
0-L A02AC02 calcium silicate WHO ATC
0-L A02AC10 combinations WHO ATC
0-L A02AD Combinations and complexes of aluminium, calcium and magnesium compounds WHO ATC
0-L A02AD01 ordinary salt combinations WHO ATC
0-L A02AD02 magaldrate WHO ATC
0-L A02AD03 almagate WHO ATC
0-L A02AD04 hydrotalcite WHO ATC
0-L A02AD05 almasilate WHO ATC
0-L A02AF Antacids with antiflatulents WHO ATC
0-L A02AF01 magaldrate and antiflatulents WHO ATC
0-L A02AF02 ordinary salt combinations and antiflatulents WHO ATC
0-L A02AG Antacids with antispasmodics WHO ATC
0-L A02AH Antacids with sodium bicarbonate WHO ATC
0-L A02AX Antacids, other combinations WHO ATC
0-L A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) WHO ATC
0-L A02BA H2-receptor antagonists WHO ATC
0-L A02BA01 cimetidine WHO ATC
0-L A02BA02 ranitidine WHO ATC
0-L A02BA03 famotidine WHO ATC
0-L A02BA04 nizatidine WHO ATC
0-L A02BA05 niperotidine WHO ATC
0-L A02BA06 roxatidine WHO ATC
0-L A02BA07 ranitidine bismuth citrate WHO ATC
0-L A02BA08 lafutidine WHO ATC
0-L A02BA51 cimetidine, combinations WHO ATC
0-L A02BA53 famotidine, combinations WHO ATC
0-L A02BB Prostaglandins WHO ATC
0-L A02BB01 misoprostol WHO ATC
0-L A02BB02 enprostil WHO ATC
0-L A02BC Proton pump inhibitors WHO ATC
0-L A02BC01 omeprazole WHO ATC
0-L A02BC02 pantoprazole WHO ATC
0-L A02BC03 lansoprazole WHO ATC
0-L A02BC04 rabeprazole WHO ATC
0-L A02BC05 esomeprazole WHO ATC
0-L A02BD Combinations for eradication of Helicobacter pylori WHO ATC
0-L A02BD01 omeprazole, amoxicillin and metronidazole WHO ATC
0-L A02BD02 lansoprazole, tetracycline and metronidazole WHO ATC
0-L A02BD03 lansoprazole, amoxicillin and metronidazole WHO ATC
0-L A02BD04 pantoprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD05 omeprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD06 esomeprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD07 lansoprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) WHO ATC
0-L A02BX01 carbenoxolone WHO ATC
0-L A02BX02 sucralfate WHO ATC
0-L A02BX03 pirenzepine WHO ATC
0-L A02BX04 methiosulfonium chloride WHO ATC
0-L A02BX05 bismuth subcitrate WHO ATC
0-L A02BX06 proglumide WHO ATC
0-L A02BX07 gefarnate WHO ATC
0-L A02BX08 sulglicotide WHO ATC
0-L A02BX09 acetoxolone WHO ATC
0-L A02BX10 zolimidine WHO ATC
0-L A02BX11 troxipide WHO ATC
0-L A02BX12 bismuth subnitrate WHO ATC
0-L A02BX13 alginic acid WHO ATC
0-L A02BX51 carbenoxolone, combinations excl. psycholeptics WHO ATC
0-L A02BX71 carbenoxolone, combinations with psycholeptics WHO ATC
0-L A02BX77 gefarnate, combinations with psycholeptics WHO ATC
0-L A02X OTHER DRUGS FOR ACID RELATED DISORDERS WHO ATC
0-L A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS WHO ATC
0-L A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS WHO ATC
0-L A03AA Synthetic anticholinergics, esters with tertiary amino group WHO ATC
0-L A03AA01 oxyphencyclimine WHO ATC
0-L A03AA03 camylofin WHO ATC
0-L A03AA04 mebeverine WHO ATC
0-L A03AA05 trimebutine WHO ATC
0-L A03AA06 rociverine WHO ATC
0-L A03AA07 dicycloverine WHO ATC
0-L A03AA08 dihexyverine WHO ATC
0-L A03AA09 difemerine WHO ATC
0-L A03AA30 piperidolate WHO ATC
0-L A03AB Synthetic anticholinergics, quaternary ammonium compounds WHO ATC
0-L A03AB01 benzilone WHO ATC
0-L A03AB02 glycopyrronium WHO ATC
0-L A03AB03 oxyphenonium WHO ATC
0-L A03AB04 penthienate WHO ATC
0-L A03AB05 propantheline WHO ATC
0-L A03AB06 otilonium bromide WHO ATC
0-L A03AB07 methantheline WHO ATC
0-L A03AB08 tridihexethyl WHO ATC
0-L A03AB09 isopropamide WHO ATC
0-L A03AB10 hexocyclium WHO ATC
0-L A03AB11 poldine WHO ATC
0-L A03AB12 mepenzolate WHO ATC
0-L A03AB13 bevonium WHO ATC
0-L A03AB14 pipenzolate WHO ATC
0-L A03AB15 diphemanil WHO ATC
0-L A03AB16 (2-benzhydryloxyethyl)diethyl-methylammonium iodide WHO ATC
0-L A03AB17 tiemonium iodide WHO ATC
0-L A03AB18 prifinium bromide WHO ATC
0-L A03AB19 timepidium bromide WHO ATC
0-L A03AB21 fenpiverinium WHO ATC
0-L A03AB53 oxyphenonium, combinations WHO ATC
0-L A03AC Synthetic antispasmodics, amides with tertiary amines WHO ATC
0-L A03AC02 dimethylaminopropionylphenothiazine WHO ATC
0-L A03AC04 nicofetamide WHO ATC
0-L A03AC05 tiropramide WHO ATC
0-L A03AD Papaverine and derivatives WHO ATC
0-L A03AD01 papaverine WHO ATC
0-L A03AD02 drotaverine WHO ATC
0-L A03AD30 moxaverine WHO ATC
0-L A03AE Drugs acting on serotonin receptors WHO ATC
0-L A03AE01 alosetron WHO ATC
0-L A03AE02 tegaserod WHO ATC
0-L A03AE03 cilansetron WHO ATC
0-L A03AE04 prucalopride WHO ATC
0-L A03AX Other drugs for functional bowel disorders WHO ATC
0-L A03AX01 fenpiprane WHO ATC
0-L A03AX02 diisopromine WHO ATC
0-L A03AX03 chlorbenzoxamine WHO ATC
0-L A03AX04 pinaverium WHO ATC
0-L A03AX05 fenoverine WHO ATC
0-L A03AX06 idanpramine WHO ATC
0-L A03AX07 proxazole WHO ATC
0-L A03AX08 alverine WHO ATC
0-L A03AX09 trepibutone WHO ATC
0-L A03AX10 isometheptene WHO ATC
0-L A03AX11 caroverine WHO ATC
0-L A03AX12 phloroglucinol WHO ATC
0-L A03AX13 silicones WHO ATC
0-L A03AX30 trimethyldiphenylpropylamine WHO ATC
0-L A03AX58 alverine, combinations WHO ATC
0-L A03B BELLADONNA AND DERIVATIVES, PLAIN WHO ATC
0-L A03BA Belladonna alkaloids, tertiary amines WHO ATC
0-L A03BA01 atropine WHO ATC
0-L A03BA03 hyoscyamine WHO ATC
0-L A03BA04 belladonna total alkaloids WHO ATC
0-L A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds WHO ATC
0-L A03BB01 butylscopolamine WHO ATC
0-L A03BB02 methylatropine WHO ATC
0-L A03BB03 methylscopolamine WHO ATC
0-L A03BB04 fentonium WHO ATC
0-L A03BB05 cimetropium bromide WHO ATC
0-L A03C ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS WHO ATC
0-L A03CA Synthetic anticholinergic agents in combination with psycholeptics WHO ATC
0-L A03CA01 isopropamide and psycholeptics WHO ATC
0-L A03CA02 clidinium and psycholeptics WHO ATC
0-L A03CA03 oxyphencyclimine and psycholeptics WHO ATC
0-L A03CA04 otilonium bromide and psycholeptics WHO ATC
0-L A03CA05 glycopyrronium and psycholeptics WHO ATC
0-L A03CA06 bevonium and psycholeptics WHO ATC
0-L A03CA07 ambutonium and psycholeptics WHO ATC
0-L A03CA08 diphemanil and psycholeptics WHO ATC
0-L A03CA30 emepronium and psycholeptics WHO ATC
0-L A03CA34 propantheline and psycholeptics WHO ATC
0-L A03CB Belladonna and derivatives in combination with psycholeptics WHO ATC
0-L A03CB01 methylscopolamine and psycholeptics WHO ATC
0-L A03CB02 belladonna total alkaloids and psycholeptics WHO ATC
0-L A03CB03 atropine and psycholeptics WHO ATC
0-L A03CB04 methylhomatropine and psycholeptics WHO ATC
0-L A03CB31 hyoscyamine and psycholeptics WHO ATC
0-L A03CC Other antispasmodics in combination with psycholeptics WHO ATC
0-L A03D ANTISPASMODICS IN COMBINATION WITH ANALGESICS WHO ATC
0-L A03DA Synthetic anticholinergic agents in combination with analgesics WHO ATC
0-L A03DA01 tropenzilone and analgesics WHO ATC
0-L A03DA02 pitofenone and analgesics WHO ATC
0-L A03DA03 bevonium and analgesics WHO ATC
0-L A03DA04 ciclonium and analgesics WHO ATC
0-L A03DA05 camylofin and analgesics WHO ATC
0-L A03DA06 trospium and analgesics WHO ATC
0-L A03DA07 tiemonium iodide and analgesics WHO ATC
0-L A03DB Belladonna and derivatives in combination with analgesics WHO ATC
0-L A03DB04 butylscopolamine and analgesics WHO ATC
0-L A03DC Other antispasmodics in combination with analgesics WHO ATC
0-L A03E ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS WHO ATC
0-L A03EA Antispasmodics, psycholeptics and analgesics in combination WHO ATC
0-L A03ED Antispasmodics in combination with other drugs WHO ATC
0-L A03F PROPULSIVES WHO ATC
0-L A03FA Propulsives WHO ATC
0-L A03FA01 metoclopramide WHO ATC
0-L A03FA02 cisapride WHO ATC
0-L A03FA03 domperidone WHO ATC
0-L A03FA04 bromopride WHO ATC
0-L A03FA05 alizapride WHO ATC
0-L A03FA06 clebopride WHO ATC
0-L A04 ANTIEMETICS AND ANTINAUSEANTS WHO ATC
0-L A04A ANTIEMETICS AND ANTINAUSEANTS WHO ATC
0-L A04AA Serotonin (5HT3) antagonists WHO ATC
0-L A04AA01 ondansetron WHO ATC
0-L A04AA02 granisetron WHO ATC
0-L A04AA03 tropisetron WHO ATC
0-L A04AA04 dolasetron WHO ATC
0-L A04AA05 palonosetron WHO ATC
0-L A04AD Other antiemetics WHO ATC
0-L A04AD01 scopolamine WHO ATC
0-L A04AD02 cerium oxalate WHO ATC
0-L A04AD04 chlorobutanol WHO ATC
0-L A04AD05 metopimazine WHO ATC
0-L A04AD10 dronabinol WHO ATC
0-L A04AD11 nabilone WHO ATC
0-L A04AD12 aprepitant WHO ATC
0-L A04AD13 casopitant WHO ATC
0-L A04AD51 scopolamine, combinations WHO ATC
0-L A04AD54 chlorobutanol, combinations WHO ATC
0-L A05 BILE AND LIVER THERAPY WHO ATC
0-L A05A BILE THERAPY WHO ATC
0-L A05AA Bile acid preparations WHO ATC
0-L A05AA01 chenodeoxycholic acid WHO ATC
0-L A05AA02 ursodeoxycholic acid WHO ATC
0-L A05AA03 cholic acid WHO ATC
0-L A05AB Preparations for biliary tract therapy WHO ATC
0-L A05AB01 nicotinyl methylamide WHO ATC
0-L A05AX Other drugs for bile therapy WHO ATC
0-L A05AX01 piprozolin WHO ATC
0-L A05AX02 hymecromone WHO ATC
0-L A05AX03 cyclobutyrol WHO ATC
0-L A05B LIVER THERAPY, LIPOTROPICS WHO ATC
0-L A05BA Liver therapy WHO ATC
0-L A05BA01 arginine glutamate WHO ATC
0-L A05BA03 silymarin WHO ATC
0-L A05BA04 citiolone WHO ATC
0-L A05BA05 epomediol WHO ATC
0-L A05BA06 ornithine oxoglurate WHO ATC
0-L A05BA07 tidiacic arginine WHO ATC
0-L A05BA08 glycyrrhizic acid WHO ATC
0-L A05C DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION WHO ATC
0-L A06 LAXATIVES WHO ATC
0-L A06A LAXATIVES WHO ATC
0-L A06AA Softeners, emollients WHO ATC
0-L A06AA01 liquid paraffin WHO ATC
0-L A06AA02 docusate sodium WHO ATC
0-L A06AA51 liquid paraffin, combinations WHO ATC
0-L A06AB Contact laxatives WHO ATC
0-L A06AB01 oxyphenisatine WHO ATC
0-L A06AB02 bisacodyl WHO ATC
0-L A06AB03 dantron WHO ATC
0-L A06AB04 phenolphthalein WHO ATC
0-L A06AB05 castor oil WHO ATC
0-L A06AB06 senna glycosides WHO ATC
0-L A06AB07 cascara WHO ATC
0-L A06AB08 sodium picosulfate WHO ATC
0-L A06AB09 bisoxatin WHO ATC
0-L A06AB20 contact laxatives in combination WHO ATC
0-L A06AB30 contact laxatives in combination with belladonna alkaloids WHO ATC
0-L A06AB52 bisacodyl, combinations WHO ATC
0-L A06AB53 dantron, combinations WHO ATC
0-L A06AB56 senna glycosides, combinations WHO ATC
0-L A06AB57 cascara, combinations WHO ATC
0-L A06AB58 sodium picosulfate, combinations WHO ATC
0-L A06AC Bulk producers WHO ATC
0-L A06AC01 ispaghula (psylla seeds) WHO ATC
0-L A06AC02 ethulose WHO ATC
0-L A06AC03 sterculia WHO ATC
0-L A06AC05 linseed WHO ATC
0-L A06AC06 methylcellulose WHO ATC
0-L A06AC07 triticum (wheat fibre) WHO ATC
0-L A06AC08 polycarbophil calcium WHO ATC
0-L A06AC51 ispaghula, combinations WHO ATC
0-L A06AC53 sterculia, combinations WHO ATC
0-L A06AC55 linseed, combinations WHO ATC
0-L A06AD Osmotically acting laxatives WHO ATC
0-L A06AD01 magnesium carbonate WHO ATC
0-L A06AD02 magnesium oxide WHO ATC
0-L A06AD03 magnesium peroxide WHO ATC
0-L A06AD04 magnesium sulfate WHO ATC
0-L A06AD10 mineral salts in combination WHO ATC
0-L A06AD11 lactulose WHO ATC
0-L A06AD12 lactitol WHO ATC
0-L A06AD13 sodium sulfate WHO ATC
0-L A06AD14 pentaerithrityl WHO ATC
0-L A06AD15 macrogol WHO ATC
0-L A06AD16 mannitol WHO ATC
0-L A06AD17 sodium phosphate WHO ATC
0-L A06AD18 sorbitol WHO ATC
0-L A06AD19 magnesium citrate WHO ATC
0-L A06AD21 sodium tartrate WHO ATC
0-L A06AD61 lactulose, combinations WHO ATC
0-L A06AD65 macrogol, combinations WHO ATC
0-L A06AG Enemas WHO ATC
0-L A06AG01 sodium phosphate WHO ATC
0-L A06AG02 bisacodyl WHO ATC
0-L A06AG03 dantron, incl. combinations WHO ATC
0-L A06AG04 glycerol WHO ATC
0-L A06AG06 oil WHO ATC
0-L A06AG07 sorbitol WHO ATC
0-L A06AG10 docusate sodium, incl. combinations WHO ATC
0-L A06AG11 laurilsulfate, incl. combinations WHO ATC
0-L A06AG20 combinations WHO ATC
0-L A06AH Peripheral opioid receptor antagonists WHO ATC
0-L A06AH01 methylnaltrexone bromide WHO ATC
0-L A06AH02 alvimopan WHO ATC
0-L A06AX Other laxatives WHO ATC
0-L A06AX01 glycerol WHO ATC
0-L A06AX02 carbon dioxide producing drugs WHO ATC
0-L A06AX03 lubiprostone WHO ATC
0-L A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVEAGENTS WHO ATC
0-L A07A INTESTINAL ANTIINFECTIVES WHO ATC
0-L A07AA Antibiotics WHO ATC
0-L A07AA01 neomycin WHO ATC
0-L A07AA02 nystatin WHO ATC
0-L A07AA03 natamycin WHO ATC
0-L A07AA04 streptomycin WHO ATC
0-L A07AA05 polymyxin B WHO ATC
0-L A07AA06 paromomycin WHO ATC
0-L A07AA07 amphotericin B WHO ATC
0-L A07AA08 kanamycin WHO ATC
0-L A07AA09 vancomycin WHO ATC
0-L A07AA10 colistin WHO ATC
0-L A07AA11 rifaximin WHO ATC
0-L A07AA51 neomycin, combinations WHO ATC
0-L A07AA54 streptomycin, combinations WHO ATC
0-L A07AB Sulfonamides WHO ATC
0-L A07AB02 phthalylsulfathiazole WHO ATC
0-L A07AB03 sulfaguanidine WHO ATC
0-L A07AB04 succinylsulfathiazole WHO ATC
0-L A07AC Imidazole derivatives WHO ATC
0-L A07AC01 miconazole WHO ATC
0-L A07AX Other intestinal antiinfectives WHO ATC
0-L A07AX01 broxyquinoline WHO ATC
0-L A07AX02 acetarsol WHO ATC
0-L A07AX03 nifuroxazide WHO ATC
0-L A07AX04 nifurzide WHO ATC
0-L A07B INTESTINAL ADSORBENTS WHO ATC
0-L A07BA Charcoal preparations WHO ATC
0-L A07BA01 medicinal charcoal WHO ATC
0-L A07BA51 medicinal charcoal, combinations WHO ATC
0-L A07BB Bismuth preparations WHO ATC
0-L A07BC Other intestinal adsorbents WHO ATC
0-L A07BC01 pectin WHO ATC
0-L A07BC02 kaolin WHO ATC
0-L A07BC03 crospovidone WHO ATC
0-L A07BC04 attapulgite WHO ATC
0-L A07BC05 diosmectite WHO ATC
0-L A07BC30 combinations WHO ATC
0-L A07BC54 attapulgite, combinations WHO ATC
0-L A07C ELECTROLYTES WITH CARBOHYDRATES WHO ATC
0-L A07CA Oral rehydration salt formulations WHO ATC
0-L A07D ANTIPROPULSIVES WHO ATC
0-L A07DA Antipropulsives WHO ATC
0-L A07DA01 diphenoxylate WHO ATC
0-L A07DA02 opium WHO ATC
0-L A07DA03 loperamide WHO ATC
0-L A07DA04 difenoxin WHO ATC
0-L A07DA05 loperamide oxide WHO ATC
0-L A07DA52 morphine, combinations WHO ATC
0-L A07DA53 loperamide, combinations WHO ATC
0-L A07E INTESTINAL ANTIINFLAMMATORY AGENTS WHO ATC
0-L A07EA Corticosteroids acting locally WHO ATC
0-L A07EA01 prednisolone WHO ATC
0-L A07EA02 hydrocortisone WHO ATC
0-L A07EA03 prednisone WHO ATC
0-L A07EA04 betamethasone WHO ATC
0-L A07EA05 tixocortol WHO ATC
0-L A07EA06 budesonide WHO ATC
0-L A07EA07 beclometasone WHO ATC
0-L A07EB Antiallergic agents, excl. corticosteroids WHO ATC
0-L A07EB01 cromoglicic acid WHO ATC
0-L A07EC Aminosalicylic acid and similar agents WHO ATC
0-L A07EC01 sulfasalazine WHO ATC
0-L A07EC02 mesalazine WHO ATC
0-L A07EC03 olsalazine WHO ATC
0-L A07EC04 balsalazide WHO ATC
0-L A07F ANTIDIARRHEAL MICROORGANISMS WHO ATC
0-L A07FA Antidiarrheal microorganisms WHO ATC
0-L A07FA01 lactic acid producing organisms WHO ATC
0-L A07FA02 saccharomyces boulardii WHO ATC
0-L A07FA51 lactic acid producing organisms, combinations WHO ATC
0-L A07X OTHER ANTIDIARRHEALS WHO ATC
0-L A07XA Other antidiarrheals WHO ATC
0-L A07XA01 albumin tannate WHO ATC
0-L A07XA02 ceratonia WHO ATC
0-L A07XA03 calcium compounds WHO ATC
0-L A07XA04 racecadotril WHO ATC
0-L A07XA51 albumin tannate, combinations WHO ATC
0-L A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS WHO ATC
0-L A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS WHO ATC
0-L A08AA Centrally acting antiobesity products WHO ATC
0-L A08AA01 phentermine WHO ATC
0-L A08AA02 fenfluramine WHO ATC
0-L A08AA03 amfepramone WHO ATC
0-L A08AA04 dexfenfluramine WHO ATC
0-L A08AA05 mazindol WHO ATC
0-L A08AA06 etilamfetamine WHO ATC
0-L A08AA07 cathine WHO ATC
0-L A08AA08 clobenzorex WHO ATC
0-L A08AA09 mefenorex WHO ATC
0-L A08AA10 sibutramine WHO ATC
0-L A08AA56 ephedrine, combinations WHO ATC
0-L A08AB Peripherally acting antiobesity products WHO ATC
0-L A08AB01 orlistat WHO ATC
0-L A08AX Other antiobesity drugs WHO ATC
0-L A08AX01 rimonabant WHO ATC
0-L A09 DIGESTIVES, INCL. ENZYMES WHO ATC
0-L A09A DIGESTIVES, INCL. ENZYMES WHO ATC
0-L A09AA Enzyme preparations WHO ATC
0-L A09AA01 diastase WHO ATC
0-L A09AA02 multienzymes (lipase, protease etc.) WHO ATC
0-L A09AA03 pepsin WHO ATC
0-L A09AA04 tilactase WHO ATC
0-L A09AB Acid preparations WHO ATC
0-L A09AB01 glutamic acid hydrochloride WHO ATC
0-L A09AB02 betaine hydrochloride WHO ATC
0-L A09AB03 hydrochloric acid WHO ATC
0-L A09AB04 citric acid WHO ATC
0-L A09AC Enzyme and acid preparations, combinations WHO ATC
0-L A09AC01 pepsin and acid preparations WHO ATC
0-L A09AC02 multienzymes and acid preparations WHO ATC
0-L A10 DRUGS USED IN DIABETES WHO ATC
0-L A10A INSULINS AND ANALOGUES WHO ATC
0-L A10AB Insulins and analogues for injection, fast-acting WHO ATC
0-L A10AB01 insulin (human) WHO ATC
0-L A10AB02 insulin (beef) WHO ATC
0-L A10AB03 insulin (pork) WHO ATC
0-L A10AB04 insulin lispro WHO ATC
0-L A10AB05 insulin aspart WHO ATC
0-L A10AB06 insulin glulisine WHO ATC
0-L A10AB30 combinations WHO ATC
0-L A10AC Insulins and analogues for injection, intermediate-acting WHO ATC
0-L A10AC01 insulin (human) WHO ATC
0-L A10AC02 insulin (beef) WHO ATC
0-L A10AC03 insulin (pork) WHO ATC
0-L A10AC04 insulin lispro WHO ATC
0-L A10AC30 combinations WHO ATC
0-L A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting WHO ATC
0-L A10AD01 insulin (human) WHO ATC
0-L A10AD02 insulin (beef) WHO ATC
0-L A10AD03 insulin (pork) WHO ATC
0-L A10AD04 Insulin lispro WHO ATC
0-L A10AD05 insulin aspart WHO ATC
0-L A10AD30 combinations WHO ATC
0-L A10AE Insulins and analogues for injection, long-acting WHO ATC
0-L A10AE01 insulin (human) WHO ATC
0-L A10AE02 insulin (beef) WHO ATC
0-L A10AE03 insulin (pork) WHO ATC
0-L A10AE04 insulin glargine WHO ATC
0-L A10AE05 insulin detemir WHO ATC
0-L A10AE30 combinations WHO ATC
0-L A10AF Insulins and analogues for inhalation WHO ATC
0-L A10AF01 insulin (human) WHO ATC
0-L A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS WHO ATC
0-L A10BA Biguanides WHO ATC
0-L A10BA01 phenformin WHO ATC
0-L A10BA02 metformin WHO ATC
0-L A10BA03 buformin WHO ATC
0-L A10BB Sulfonamides, urea derivatives WHO ATC
0-L A10BB01 glibenclamide WHO ATC
0-L A10BB02 chlorpropamide WHO ATC
0-L A10BB03 tolbutamide WHO ATC
0-L A10BB04 glibornuride WHO ATC
0-L A10BB05 tolazamide WHO ATC
0-L A10BB06 carbutamide WHO ATC
0-L A10BB07 glipizide WHO ATC
0-L A10BB08 gliquidone WHO ATC
0-L A10BB09 gliclazide WHO ATC
0-L A10BB10 metahexamide WHO ATC
0-L A10BB11 glisoxepide WHO ATC
0-L A10BB12 glimepiride WHO ATC
0-L A10BB31 acetohexamide WHO ATC
0-L A10BC Sulfonamides (heterocyclic) WHO ATC
0-L A10BC01 glymidine WHO ATC
0-L A10BD Combinations of oral blood glucose lowering drugs WHO ATC
0-L A10BD01 phenformin and sulfonamides WHO ATC
0-L A10BD02 metformin and sulfonamides WHO ATC
0-L A10BD03 metformin and rosiglitazone WHO ATC
0-L A10BD04 glimepiride and rosiglitazone WHO ATC
0-L A10BD05 metformin and pioglitazone WHO ATC
0-L A10BD06 glimepiride and pioglitazone WHO ATC
0-L A10BD07 metformin and sitagliptin WHO ATC
0-L A10BD08 metformin and vildagliptin WHO ATC
0-L A10BD09 pioglitazone and alogliptin WHO ATC
0-L A10BF Alpha glucosidase inhibitors WHO ATC
0-L A10BF01 acarbose WHO ATC
0-L A10BF02 miglitol WHO ATC
0-L A10BF03 voglibose WHO ATC
0-L A10BG Thiazolidinediones WHO ATC
0-L A10BG01 troglitazone WHO ATC
0-L A10BG02 rosiglitazone WHO ATC
0-L A10BG03 pioglitazone WHO ATC
0-L A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors WHO ATC
0-L A10BH01 sitagliptin WHO ATC
0-L A10BH02 vildagliptin WHO ATC
0-L A10BH03 saxagliptin WHO ATC
0-L A10BH04 alogliptin WHO ATC
0-L A10BX Other blood glucose lowering drugs, excl. insulins WHO ATC
0-L A10BX01 guar gum WHO ATC
0-L A10BX02 repaglinide WHO ATC
0-L A10BX03 nateglinide WHO ATC
0-L A10BX04 exenatide WHO ATC
0-L A10BX05 pramlintide WHO ATC
0-L A10BX06 benfluorex WHO ATC
0-L A10BX07 liraglutide WHO ATC
0-L A10BX08 mitiglinide WHO ATC
0-L A10X OTHER DRUGS USED IN DIABETES WHO ATC
0-L A10XA Aldose reductase inhibitors WHO ATC
0-L A10XA01 tolrestat WHO ATC
0-L A11 VITAMINS WHO ATC
0-L A11A MULTIVITAMINS, COMBINATIONS WHO ATC
0-L A11AA Multivitamins with minerals WHO ATC
0-L A11AA01 multivitamins and iron WHO ATC
0-L A11AA02 multivitamins and calcium WHO ATC
0-L A11AA03 multivitamins and other minerals, incl. combinations WHO ATC
0-L A11AA04 multivitamins and trace elements WHO ATC
0-L A11AB Multivitamins, other combinations WHO ATC
0-L A11B MULTIVITAMINS, PLAIN WHO ATC
0-L A11BA Multivitamins, plain WHO ATC
0-L A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO WHO ATC
0-L A11CA Vitamin A, plain WHO ATC
0-L A11CA01 retinol (vit A) WHO ATC
0-L A11CA02 betacarotene WHO ATC
0-L A11CB Vitamin A and D in combination WHO ATC
0-L A11CC Vitamin D and analogues WHO ATC
0-L A11CC01 ergocalciferol WHO ATC
0-L A11CC02 dihydrotachysterol WHO ATC
0-L A11CC03 alfacalcidol WHO ATC
0-L A11CC04 calcitriol WHO ATC
0-L A11CC05 colecalciferol WHO ATC
0-L A11CC06 calcifediol WHO ATC
0-L A11CC20 combinations WHO ATC
0-L A11D VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 WHO ATC
0-L A11DA Vitamin B1, plain WHO ATC
0-L A11DA01 thiamine (vit B1) WHO ATC
0-L A11DA02 sulbutiamine WHO ATC
0-L A11DA03 benfotiamine WHO ATC
0-L A11DB Vitamin B1 in combination with vitamin B6 and/or vitamin B12 WHO ATC
0-L A11E VITAMIN B-COMPLEX, INCL. COMBINATIONS WHO ATC
0-L A11EA Vitamin B-complex, plain WHO ATC
0-L A11EB Vitamin B-complex with vitamin C WHO ATC
0-L A11EC Vitamin B-complex with minerals WHO ATC
0-L A11ED Vitamin B-complex with anabolic steroids WHO ATC
0-L A11EX Vitamin B-complex, other combinations WHO ATC
0-L A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS WHO ATC
0-L A11GA Ascorbic acid (vitamin C), plain WHO ATC
0-L A11GA01 ascorbic acid (vit C) WHO ATC
0-L A11GB Ascorbic acid (vitamin C), combinations WHO ATC
0-L A11GB01 ascorbic acid (vit C) and calcium WHO ATC
0-L A11H OTHER PLAIN VITAMIN PREPARATIONS WHO ATC
0-L A11HA Other plain vitamin preparations WHO ATC
0-L A11HA01 nicotinamide WHO ATC
0-L A11HA02 pyridoxine (vit B6) WHO ATC
0-L A11HA03 tocopherol (vit E) WHO ATC
0-L A11HA04 riboflavin (vit B2) WHO ATC
0-L A11HA05 biotin WHO ATC
0-L A11HA06 pyridoxal phosphate WHO ATC
0-L A11HA07 inositol WHO ATC
0-L A11HA08 tocofersolan WHO ATC
0-L A11HA30 dexpanthenol WHO ATC
0-L A11HA31 calcium pantothenate WHO ATC
0-L A11HA32 pantethine WHO ATC
0-L A11J OTHER VITAMIN PRODUCTS, COMBINATIONS WHO ATC
0-L A11JA Combinations of vitamins WHO ATC
0-L A11JB Vitamins with minerals WHO ATC
0-L A11JC Vitamins, other combinations WHO ATC
0-L A12 MINERAL SUPPLEMENTS WHO ATC
0-L A12A CALCIUM WHO ATC
0-L A12AA Calcium WHO ATC
0-L A12AA01 calcium phosphate WHO ATC
0-L A12AA02 calcium glubionate WHO ATC
0-L A12AA03 calcium gluconate WHO ATC
0-L A12AA04 calcium carbonate WHO ATC
0-L A12AA05 calcium lactate WHO ATC
0-L A12AA06 calcium lactate gluconate WHO ATC
0-L A12AA07 calcium chloride WHO ATC
0-L A12AA08 calcium glycerylphosphate WHO ATC
0-L A12AA09 calcium citrate lysine complex WHO ATC
0-L A12AA10 calcium glucoheptonate WHO ATC
0-L A12AA11 calcium pangamate WHO ATC
0-L A12AA12 calcium acetate anhydrous WHO ATC
0-L A12AA20 calcium (different salts in combination) WHO ATC
0-L A12AA30 calcium laevulate WHO ATC
0-L A12AX Calcium, combinations with other drugs WHO ATC
0-L A12B POTASSIUM WHO ATC
0-L A12BA Potassium WHO ATC
0-L A12BA01 potassium chloride WHO ATC
0-L A12BA02 potassium citrate WHO ATC
0-L A12BA03 potassium hydrogentartrate WHO ATC
0-L A12BA04 potassium hydrogencarbonate WHO ATC
0-L A12BA05 potassium gluconate WHO ATC
0-L A12BA30 combinations WHO ATC
0-L A12BA51 potassium chloride, combinations WHO ATC
0-L A12C OTHER MINERAL SUPPLEMENTS WHO ATC
0-L A12CA Sodium WHO ATC
0-L A12CA01 sodium chloride WHO ATC
0-L A12CA02 sodium sulfate WHO ATC
0-L A12CB Zinc WHO ATC
0-L A12CB01 zinc sulfate WHO ATC
0-L A12CB02 zinc gluconate WHO ATC
0-L A12CB03 zinc protein complex WHO ATC
0-L A12CC Magnesium WHO ATC
0-L A12CC01 magnesium chloride WHO ATC
0-L A12CC02 magnesium sulfate WHO ATC
0-L A12CC03 magnesium gluconate WHO ATC
0-L A12CC04 magnesium citrate WHO ATC
0-L A12CC05 magnesium aspartate WHO ATC
0-L A12CC06 magnesium lactate WHO ATC
0-L A12CC07 magnesium levulinate WHO ATC
0-L A12CC08 magnesium pidolate WHO ATC
0-L A12CC09 magnesium orotate WHO ATC
0-L A12CC10 magnesium oxide WHO ATC
0-L A12CC30 magnesium (different salts in combination) WHO ATC
0-L A12CD Fluoride WHO ATC
0-L A12CD01 sodium fluoride WHO ATC
0-L A12CD02 sodium monofluorophosphate WHO ATC
0-L A12CD51 fluoride, combinations WHO ATC
0-L A12CE Selenium WHO ATC
0-L A12CE01 sodium selenate WHO ATC
0-L A12CE02 sodium selenite WHO ATC
0-L A12CX Other mineral products WHO ATC
0-L A13 TONICS WHO ATC
0-L A13A TONICS WHO ATC
0-L A14 ANABOLIC AGENTS FOR SYSTEMIC USE WHO ATC
0-L A14A ANABOLIC STEROIDS WHO ATC
0-L A14AA Androstan derivatives WHO ATC
0-L A14AA01 androstanolone WHO ATC
0-L A14AA02 stanozolol WHO ATC
0-L A14AA03 metandienone WHO ATC
0-L A14AA04 metenolone WHO ATC
0-L A14AA05 oxymetholone WHO ATC
0-L A14AA06 quinbolone WHO ATC
0-L A14AA07 prasterone WHO ATC
0-L A14AA08 oxandrolone WHO ATC
0-L A14AA09 norethandrolone WHO ATC
0-L A14AB Estren derivatives WHO ATC
0-L A14AB01 nandrolone WHO ATC
0-L A14AB02 ethylestrenol WHO ATC
0-L A14AB03 oxabolone cipionate WHO ATC
0-L A14B OTHER ANABOLIC AGENTS WHO ATC
0-L A15 APPETITE STIMULANTS WHO ATC
0-L A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS WHO ATC
0-L A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS WHO ATC
0-L A16AA Amino acids and derivatives WHO ATC
0-L A16AA01 levocarnitine WHO ATC
0-L A16AA02 ademetionine WHO ATC
0-L A16AA03 glutamine WHO ATC
0-L A16AA04 mercaptamine WHO ATC
0-L A16AA05 carglumic acid WHO ATC
0-L A16AA06 betaine WHO ATC
0-L A16AB Enzymes WHO ATC
0-L A16AB01 alglucerase WHO ATC
0-L A16AB02 imiglucerase WHO ATC
0-L A16AB03 agalsidase alfa WHO ATC
0-L A16AB04 agalsidase beta WHO ATC
0-L A16AB05 laronidase WHO ATC
0-L A16AB06 sacrosidase WHO ATC
0-L A16AB07 alglucosidase alfa WHO ATC
0-L A16AB08 galsulfase WHO ATC
0-L A16AB09 idursulfase WHO ATC
0-L A16AX Various alimentary tract and metabolism products WHO ATC
0-L A16AX01 tioctic acid WHO ATC
0-L A16AX02 anethole trithione WHO ATC
0-L A16AX03 sodium phenylbutyrate WHO ATC
0-L A16AX04 nitisinone WHO ATC
0-L A16AX05 zinc acetate WHO ATC
0-L A16AX06 miglustat WHO ATC
0-L A16AX07 sapropterin WHO ATC
0-L B BLOOD AND BLOOD FORMING ORGANS WHO ATC
0-L B01 ANTITHROMBOTIC AGENTS WHO ATC
0-L B01A ANTITHROMBOTIC AGENTS WHO ATC
0-L B01AA Vitamin K antagonists WHO ATC
0-L B01AA01 dicoumarol WHO ATC
0-L B01AA02 phenindione WHO ATC
0-L B01AA03 warfarin WHO ATC
0-L B01AA04 phenprocoumon WHO ATC
0-L B01AA07 acenocoumarol WHO ATC
0-L B01AA08 ethyl biscoumacetate WHO ATC
0-L B01AA09 clorindione WHO ATC
0-L B01AA10 diphenadione WHO ATC
0-L B01AA11 tioclomarol WHO ATC
0-L B01AB Heparin group WHO ATC
0-L B01AB01 heparin WHO ATC
0-L B01AB02 antithrombin III WHO ATC
0-L B01AB04 dalteparin WHO ATC
0-L B01AB05 enoxaparin WHO ATC
0-L B01AB06 nadroparin WHO ATC
0-L B01AB07 parnaparin WHO ATC
0-L B01AB08 reviparin WHO ATC
0-L B01AB09 danaparoid WHO ATC
0-L B01AB10 tinzaparin WHO ATC
0-L B01AB11 sulodexide WHO ATC
0-L B01AB12 bemiparin WHO ATC
0-L B01AB51 heparin, combinations WHO ATC
0-L B01AC Platelet aggregation inhibitors excl. heparin WHO ATC
0-L B01AC01 ditazole WHO ATC
0-L B01AC02 cloricromen WHO ATC
0-L B01AC03 picotamide WHO ATC
0-L B01AC04 clopidogrel WHO ATC
0-L B01AC05 ticlopidine WHO ATC
0-L B01AC06 acetylsalicylic acid WHO ATC
0-L B01AC07 dipyridamole WHO ATC
0-L B01AC08 carbasalate calcium WHO ATC
0-L B01AC09 epoprostenol WHO ATC
0-L B01AC10 indobufen WHO ATC
0-L B01AC11 iloprost WHO ATC
0-L B01AC13 abciximab WHO ATC
0-L B01AC15 aloxiprin WHO ATC
0-L B01AC16 eptifibatide WHO ATC
0-L B01AC17 tirofiban WHO ATC
0-L B01AC18 triflusal WHO ATC
0-L B01AC19 beraprost WHO ATC
0-L B01AC21 treprostinil WHO ATC
0-L B01AC22 prasugrel WHO ATC
0-L B01AC30 combinations WHO ATC
0-L B01AD Enzymes WHO ATC
0-L B01AD01 streptokinase WHO ATC
0-L B01AD02 alteplase WHO ATC
0-L B01AD03 anistreplase WHO ATC
0-L B01AD04 urokinase WHO ATC
0-L B01AD05 fibrinolysin WHO ATC
0-L B01AD06 brinase WHO ATC
0-L B01AD07 reteplase WHO ATC
0-L B01AD08 saruplase WHO ATC
0-L B01AD09 ancrod WHO ATC
0-L B01AD10 drotrecogin alfa (activated) WHO ATC
0-L B01AD11 tenecteplase WHO ATC
0-L B01AD12 protein C WHO ATC
0-L B01AE Direct thrombin inhibitors WHO ATC
0-L B01AE01 desirudin WHO ATC
0-L B01AE02 lepirudin WHO ATC
0-L B01AE03 argatroban WHO ATC
0-L B01AE04 melagatran WHO ATC
0-L B01AE05 ximelagatran WHO ATC
0-L B01AE06 bivalirudin WHO ATC
0-L B01AE07 dabigatran etexilate WHO ATC
0-L B01AX Other antithrombotic agents WHO ATC
0-L B01AX01 defibrotide WHO ATC
0-L B01AX04 dermatan sulfate WHO ATC
0-L B01AX05 fondaparinux WHO ATC
0-L B01AX06 rivaroxaban WHO ATC
0-L B02 ANTIHEMORRHAGICS WHO ATC
0-L B02A ANTIFIBRINOLYTICS WHO ATC
0-L B02AA Amino acids WHO ATC
0-L B02AA01 aminocaproic acid WHO ATC
0-L B02AA02 tranexamic acid WHO ATC
0-L B02AA03 aminomethylbenzoic acid WHO ATC
0-L B02AB Proteinase inhibitors WHO ATC
0-L B02AB01 aprotinin WHO ATC
0-L B02AB02 alfa1 antitrypsin WHO ATC
0-L B02AB03 c1-inhibitor WHO ATC
0-L B02AB04 camostat WHO ATC
0-L B02B VITAMIN K AND OTHER HEMOSTATICS WHO ATC
0-L B02BA Vitamin K WHO ATC
0-L B02BA01 phytomenadione WHO ATC
0-L B02BA02 menadione WHO ATC
0-L B02BB Fibrinogen WHO ATC
0-L B02BB01 human fibrinogen WHO ATC
0-L B02BC Local hemostatics WHO ATC
0-L B02BC01 absorbable gelatin sponge WHO ATC
0-L B02BC02 oxidized cellulose WHO ATC
0-L B02BC03 tetragalacturonic acid hydroxymethylester WHO ATC
0-L B02BC05 adrenalone WHO ATC
0-L B02BC06 thrombin WHO ATC
0-L B02BC07 collagen WHO ATC
0-L B02BC08 calcium alginate WHO ATC
0-L B02BC09 epinephrine WHO ATC
0-L B02BC10 fibrinogen, human WHO ATC
0-L B02BC30 combinations WHO ATC
0-L B02BD Blood coagulation factors WHO ATC
0-L B02BD01 coagulation factor IX, II, VII and X in combination WHO ATC
0-L B02BD02 coagulation factor VIII WHO ATC
0-L B02BD03 factor VIII inhibitor bypassing activity WHO ATC
0-L B02BD04 coagulation factor IX WHO ATC
0-L B02BD05 coagulation factor VII WHO ATC
0-L B02BD06 von Willebrand factor and coagulation factor VIII in combination WHO ATC
0-L B02BD07 coagulation factor XIII WHO ATC
0-L B02BD08 eptacog alfa (activated) WHO ATC
0-L B02BD09 nonacog alfa WHO ATC
0-L B02BD30 thrombin WHO ATC
0-L B02BX Other systemic hemostatics WHO ATC
0-L B02BX01 etamsylate WHO ATC
0-L B02BX02 carbazochrome WHO ATC
0-L B02BX03 batroxobin WHO ATC
0-L B02BX04 romiplostim WHO ATC
0-L B02BX05 eltrombopag WHO ATC
0-L B03 ANTIANEMIC PREPARATIONS WHO ATC
0-L B03A IRON PREPARATIONS WHO ATC
0-L B03AA Iron bivalent, oral preparations WHO ATC
0-L B03AA01 ferrous glycine sulfate WHO ATC
0-L B03AA02 ferrous fumarate WHO ATC
0-L B03AA03 ferrous gluconate WHO ATC
0-L B03AA04 ferrous carbonate WHO ATC
0-L B03AA05 ferrous chloride WHO ATC
0-L B03AA06 ferrous succinate WHO ATC
0-L B03AA07 ferrous sulfate WHO ATC
0-L B03AA08 ferrous tartrate WHO ATC
0-L B03AA09 ferrous aspartate WHO ATC
0-L B03AA10 ferrous ascorbate WHO ATC
0-L B03AA11 ferrous iodine WHO ATC
0-L B03AB Iron trivalent, oral preparations WHO ATC
0-L B03AB01 ferric sodium citrate WHO ATC
0-L B03AB02 saccharated iron oxide WHO ATC
0-L B03AB03 sodium feredetate WHO ATC
0-L B03AB04 ferric hydroxide WHO ATC
0-L B03AB05 dextriferron WHO ATC
0-L B03AB06 ferric citrate WHO ATC
0-L B03AB07 chondroitin sulfate-iron complex WHO ATC
0-L B03AB08 ferric acetyl transferrin WHO ATC
0-L B03AB09 ferric proteinsuccinylate WHO ATC
0-L B03AC Iron trivalent, parenteral preparations WHO ATC
0-L B03AC01 dextriferron WHO ATC
0-L B03AC02 saccharated iron oxide WHO ATC
0-L B03AC03 iron-sorbitol-citric acid complex WHO ATC
0-L B03AC05 ferric sorbitol gluconic acid complex WHO ATC
0-L B03AC06 ferric oxide dextran complex WHO ATC
0-L B03AC07 ferric sodium gluconate complex WHO ATC
0-L B03AD Iron in combination with folic acid WHO ATC
0-L B03AD01 ferrous amino acid complex WHO ATC
0-L B03AD02 ferrous fumarate WHO ATC
0-L B03AD03 ferrous sulfate WHO ATC
0-L B03AD04 dextriferron WHO ATC
0-L B03AE Iron in other combinations WHO ATC
0-L B03AE01 iron, vitamin B12 and folic acid WHO ATC
0-L B03AE02 iron, multivitamins and folic acid WHO ATC
0-L B03AE03 iron and multivitamins WHO ATC
0-L B03AE04 iron, multivitamins and minerals WHO ATC
0-L B03AE10 various combinations WHO ATC
0-L B03B VITAMIN B12 AND FOLIC ACID WHO ATC
0-L B03BA Vitamin B12 (cyanocobalamin and analogues) WHO ATC
0-L B03BA01 cyanocobalamin WHO ATC
0-L B03BA02 cyanocobalamin tannin complex WHO ATC
0-L B03BA03 hydroxocobalamin WHO ATC
0-L B03BA04 cobamamide WHO ATC
0-L B03BA05 mecobalamin WHO ATC
0-L B03BA51 cyanocobalamin, combinations WHO ATC
0-L B03BA53 hydroxocobalamin, combinations WHO ATC
0-L B03BB Folic acid and derivatives WHO ATC
0-L B03BB01 folic acid WHO ATC
0-L B03BB51 folic acid, combinations WHO ATC
0-L B03X OTHER ANTIANEMIC PREPARATIONS WHO ATC
0-L B03XA Other antianemic preparations WHO ATC
0-L B03XA01 erythropoietin WHO ATC
0-L B03XA02 darbepoetin alfa WHO ATC
0-L B03XA03 methoxy polyethylene glycol-epoetin beta WHO ATC
0-L B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS WHO ATC
0-L B05A BLOOD AND RELATED PRODUCTS WHO ATC
0-L B05AA Blood substitutes and plasma protein fractions WHO ATC
0-L B05AA01 albumin WHO ATC
0-L B05AA02 other plasma protein fractions WHO ATC
0-L B05AA03 fluorocarbon blood substitutes WHO ATC
0-L B05AA05 dextran WHO ATC
0-L B05AA06 gelatin agents WHO ATC
0-L B05AA07 hydroxyethylstarch WHO ATC
0-L B05AA08 hemoglobin crosfumaril WHO ATC
0-L B05AA09 hemoglobin raffimer WHO ATC
0-L B05AA10 hemoglobin glutamer (bovine) WHO ATC
0-L B05AX Other blood products WHO ATC
0-L B05AX01 erythrocytes WHO ATC
0-L B05AX02 thrombocytes WHO ATC
0-L B05AX03 blood plasma WHO ATC
0-L B05AX04 stem cells from umbilical cord blood WHO ATC
0-L B05B I.V. SOLUTIONS WHO ATC
0-L B05BA Solutions for parenteral nutrition WHO ATC
0-L B05BA01 amino acids WHO ATC
0-L B05BA02 fat emulsions WHO ATC
0-L B05BA03 carbohydrates WHO ATC
0-L B05BA04 protein hydrolysates WHO ATC
0-L B05BA10 combinations WHO ATC
0-L B05BB Solutions affecting the electrolyte balance WHO ATC
0-L B05BB01 electrolytes WHO ATC
0-L B05BB02 electrolytes with carbohydrates WHO ATC
0-L B05BB03 trometamol WHO ATC
0-L B05BC Solutions producing osmotic diuresis WHO ATC
0-L B05BC01 mannitol WHO ATC
0-L B05BC02 carbamide WHO ATC
0-L B05C IRRIGATING SOLUTIONS WHO ATC
0-L B05CA Antiinfectives WHO ATC
0-L B05CA01 cetylpyridinium WHO ATC
0-L B05CA02 chlorhexidine WHO ATC
0-L B05CA03 nitrofural WHO ATC
0-L B05CA04 sulfamethizole WHO ATC
0-L B05CA05 taurolidine WHO ATC
0-L B05CA06 mandelic acid WHO ATC
0-L B05CA07 noxytiolin WHO ATC
0-L B05CA08 ethacridine lactate WHO ATC
0-L B05CA09 neomycin WHO ATC
0-L B05CA10 combinations WHO ATC
0-L B05CB Salt solutions WHO ATC
0-L B05CB01 sodium chloride WHO ATC
0-L B05CB02 sodium citrate WHO ATC
0-L B05CB03 magnesium citrate WHO ATC
0-L B05CB04 sodium bicarbonate WHO ATC
0-L B05CB10 combinations WHO ATC
0-L B05CX Other irrigating solutions WHO ATC
0-L B05CX01 glucose WHO ATC
0-L B05CX02 sorbitol WHO ATC
0-L B05CX03 glycine WHO ATC
0-L B05CX04 mannitol WHO ATC
0-L B05CX10 combinations WHO ATC
0-L B05D PERITONEAL DIALYTICS WHO ATC
0-L B05DA Isotonic solutions WHO ATC
0-L B05DB Hypertonic solutions WHO ATC
0-L B05X I.V. SOLUTION ADDITIVES WHO ATC
0-L B05XA Electrolyte solutions WHO ATC
0-L B05XA01 potassium chloride WHO ATC
0-L B05XA02 sodium bicarbonate WHO ATC
0-L B05XA03 sodium chloride WHO ATC
0-L B05XA04 ammonium chloride WHO ATC
0-L B05XA05 magnesium sulfate WHO ATC
0-L B05XA06 potassium phosphate, incl. comb. with other potassium salts WHO ATC
0-L B05XA07 calcium chloride WHO ATC
0-L B05XA08 sodium acetate WHO ATC
0-L B05XA09 sodium phosphate WHO ATC
0-L B05XA10 magnesium phosphate WHO ATC
0-L B05XA11 magnesium chloride WHO ATC
0-L B05XA12 zinc chloride WHO ATC
0-L B05XA13 hydrochloric acid WHO ATC
0-L B05XA14 sodium glycerophosphate WHO ATC
0-L B05XA15 potassium lactate WHO ATC
0-L B05XA16 cardioplegia solutions WHO ATC
0-L B05XA17 potassium acetate WHO ATC
0-L B05XA30 combinations of electrolytes WHO ATC
0-L B05XA31 electrolytes in combination with other drugs WHO ATC
0-L B05XB Amino acids WHO ATC
0-L B05XB01 arginine hydrochloride WHO ATC
0-L B05XB02 alanyl glutamine WHO ATC
0-L B05XB03 lysine WHO ATC
0-L B05XC Vitamins WHO ATC
0-L B05XX Other i.v. solution additives WHO ATC
0-L B05XX02 trometamol WHO ATC
0-L B05Z HEMODIALYTICS AND HEMOFILTRATES WHO ATC
0-L B05ZA Hemodialytics, concentrates WHO ATC
0-L B05ZB Hemofiltrates WHO ATC
0-L B06 OTHER HEMATOLOGICAL AGENTS WHO ATC
0-L B06A OTHER HEMATOLOGICAL AGENTS WHO ATC
0-L B06AA Enzymes WHO ATC
0-L B06AA02 fibrinolysin and desoxyribonuclease WHO ATC
0-L B06AA03 hyaluronidase WHO ATC
0-L B06AA04 chymotrypsin WHO ATC
0-L B06AA07 trypsin WHO ATC
0-L B06AA10 desoxyribonuclease WHO ATC
0-L B06AA11 bromelains WHO ATC
0-L B06AA55 streptokinase, combinations WHO ATC
0-L B06AB Other hem products WHO ATC
0-L B06AB01 hematin WHO ATC
0-L C CARDIOVASCULAR SYSTEM WHO ATC
0-L C01 CARDIAC THERAPY WHO ATC
0-L C01A CARDIAC GLYCOSIDES WHO ATC
0-L C01AA Digitalis glycosides WHO ATC
0-L C01AA01 acetyldigitoxin WHO ATC
0-L C01AA02 acetyldigoxin WHO ATC
0-L C01AA03 digitalis leaves WHO ATC
0-L C01AA04 digitoxin WHO ATC
0-L C01AA05 digoxin WHO ATC
0-L C01AA06 lanatoside C WHO ATC
0-L C01AA07 deslanoside WHO ATC
0-L C01AA08 metildigoxin WHO ATC
0-L C01AA09 gitoformate WHO ATC
0-L C01AA52 acetyldigoxin, combinations WHO ATC
0-L C01AB Scilla glycosides WHO ATC
0-L C01AB01 proscillaridin WHO ATC
0-L C01AB51 proscillaridin, combinations WHO ATC
0-L C01AC Strophantus glycosides WHO ATC
0-L C01AC01 g-strophanthin WHO ATC
0-L C01AC03 cymarin WHO ATC
0-L C01AX Other cardiac glycosides WHO ATC
0-L C01AX02 peruvoside WHO ATC
0-L C01B ANTIARRHYTHMICS, CLASS I AND III WHO ATC
0-L C01BA Antiarrhythmics, class Ia WHO ATC
0-L C01BA01 quinidine WHO ATC
0-L C01BA02 procainamide WHO ATC
0-L C01BA03 disopyramide WHO ATC
0-L C01BA04 sparteine WHO ATC
0-L C01BA05 ajmaline WHO ATC
0-L C01BA08 prajmaline WHO ATC
0-L C01BA12 lorajmine WHO ATC
0-L C01BA51 quinidine, combinations excl. psycholeptics WHO ATC
0-L C01BA71 quinidine, combinations with psycholeptics WHO ATC
0-L C01BB Antiarrhythmics, class Ib WHO ATC
0-L C01BB01 lidocaine WHO ATC
0-L C01BB02 mexiletine WHO ATC
0-L C01BB03 tocainide WHO ATC
0-L C01BB04 aprindine WHO ATC
0-L C01BC Antiarrhythmics, class Ic WHO ATC
0-L C01BC03 propafenone WHO ATC
0-L C01BC04 flecainide WHO ATC
0-L C01BC07 lorcainide WHO ATC
0-L C01BC08 encainide WHO ATC
0-L C01BD Antiarrhythmics, class III WHO ATC
0-L C01BD01 amiodarone WHO ATC
0-L C01BD02 bretylium tosilate WHO ATC
0-L C01BD03 bunaftine WHO ATC
0-L C01BD04 dofetilide WHO ATC
0-L C01BD05 ibutilide WHO ATC
0-L C01BD06 tedisamil WHO ATC
0-L C01BG Other class I antiarrhythmics WHO ATC
0-L C01BG01 moracizine WHO ATC
0-L C01BG07 cibenzoline WHO ATC
0-L C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES WHO ATC
0-L C01CA Adrenergic and dopaminergic agents WHO ATC
0-L C01CA01 etilefrine WHO ATC
0-L C01CA02 isoprenaline WHO ATC
0-L C01CA03 norepinephrine WHO ATC
0-L C01CA04 dopamine WHO ATC
0-L C01CA05 norfenefrine WHO ATC
0-L C01CA06 phenylephrine WHO ATC
0-L C01CA07 dobutamine WHO ATC
0-L C01CA08 oxedrine WHO ATC
0-L C01CA09 metaraminol WHO ATC
0-L C01CA10 methoxamine WHO ATC
0-L C01CA11 mephentermine WHO ATC
0-L C01CA12 dimetofrine WHO ATC
0-L C01CA13 prenalterol WHO ATC
0-L C01CA14 dopexamine WHO ATC
0-L C01CA15 gepefrine WHO ATC
0-L C01CA16 ibopamine WHO ATC
0-L C01CA17 midodrine WHO ATC
0-L C01CA18 octopamine WHO ATC
0-L C01CA19 fenoldopam WHO ATC
0-L C01CA21 cafedrine WHO ATC
0-L C01CA22 arbutamine WHO ATC
0-L C01CA23 theodrenaline WHO ATC
0-L C01CA24 epinephrine WHO ATC
0-L C01CA30 combinations WHO ATC
0-L C01CA51 etilefrine, combinations WHO ATC
0-L C01CE Phosphodiesterase inhibitors WHO ATC
0-L C01CE01 amrinone WHO ATC
0-L C01CE02 milrinone WHO ATC
0-L C01CE03 enoximone WHO ATC
0-L C01CE04 bucladesine WHO ATC
0-L C01CX Other cardiac stimulants WHO ATC
0-L C01CX06 angiotensinamide WHO ATC
0-L C01CX07 xamoterol WHO ATC
0-L C01CX08 levosimendan WHO ATC
0-L C01D VASODILATORS USED IN CARDIAC DISEASES WHO ATC
0-L C01DA Organic nitrates WHO ATC
0-L C01DA02 glyceryl trinitrate WHO ATC
0-L C01DA04 methylpropylpropanediol dinitrate WHO ATC
0-L C01DA05 pentaerithrityl tetranitrate WHO ATC
0-L C01DA07 propatylnitrate WHO ATC
0-L C01DA08 isosorbide dinitrate WHO ATC
0-L C01DA09 trolnitrate WHO ATC
0-L C01DA13 eritrityl tetranitrate WHO ATC
0-L C01DA14 isosorbide mononitrate WHO ATC
0-L C01DA20 organic nitrates in combination WHO ATC
0-L C01DA38 tenitramine WHO ATC
0-L C01DA52 glyceryl trinitrate, combinations WHO ATC
0-L C01DA54 methylpropylpropanediol dinitrate, combinations WHO ATC
0-L C01DA55 pentaerithrityl tetranitrate, combinations WHO ATC